<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">CHP</journal-id>
<journal-id journal-id-type="hwp">spchp</journal-id>
<journal-title>Journal of Evidence-Based Complementary &amp; Alternative Medicine</journal-title>
<issn pub-type="ppub">2156-5872</issn>
<issn pub-type="epub">2156-5899</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/2156587213477864</article-id>
<article-id pub-id-type="publisher-id">10.1177_2156587213477864</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Topical Review Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Newly Developed Synbiotics and the Chemotherapy-Damaged Gut</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Hanru</given-names>
</name>
<degrees>MSC</degrees>
<xref ref-type="aff" rid="aff1-2156587213477864">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bastian</surname>
<given-names>Susan E. P.</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff2-2156587213477864">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Howarth</surname>
<given-names>Gordon S.</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff1-2156587213477864">1</xref>
<xref ref-type="aff" rid="aff3-2156587213477864">3</xref>
<xref ref-type="corresp" rid="corresp1-2156587213477864"/>
</contrib>
</contrib-group>
<aff id="aff1-2156587213477864"><label>1</label>School of Animal and Veterinary Sciences; University of Adelaide, Roseworthy Campus, South Australia, Australia</aff>
<aff id="aff2-2156587213477864"><label>2</label>School of Agriculture, Food and Wine; University of Adelaide, Waite Campus, South Australia, Australia</aff>
<aff id="aff3-2156587213477864"><label>3</label>Centre for Paediatric and Adolescent Gastroenterology, Children, Youth and Women’s Health Service, North Adelaide, South Australia, Australia</aff>
<author-notes>
<corresp id="corresp1-2156587213477864">Gordon S. Howarth, PhD, School of Animal and Veterinary Sciences, University of Adelaide, Roseworthy Campus, South Australia, Australia. Email: <email>gordon.howarth@adelaide.edu.au</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>7</month>
<year>2013</year>
</pub-date>
<volume>18</volume>
<issue>3</issue>
<fpage>198</fpage>
<lpage>208</lpage>
<history>
<date date-type="received">
<day>15</day>
<month>1</month>
<year>2013</year>
</date>
<date date-type="accepted">
<day>16</day>
<month>1</month>
<year>2013</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2013</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Mucositis is a common side-effect of cancer chemotherapy and radiotherapy. Features of mucositis include erythema, ulceration, and inflammation of the gastrointestinal tract accompanied by clinical symptoms of abdominal pain and digestive disturbances. New treatment strategies are required. Experimental evidence is accumulating showing therapeutic promise for new nutraceutical agents including probiotic bacteria, probiotic-derived factors, prebiotics, and plant extracts. However, the targeted development of new combinations of these agents (synbiotics) to combat mucositis remains largely unexplored. The current review addresses the potential for these nutraceutical agents to reduce the severity of chemotherapy-damaged mucositis by strategically aligning their underlying mechanism of action with features of mucositis pathogenesis. The potential for certain plant extracts to act as prebiotics, in combination with probiotics or their derived factors, is further investigated. These unique synbiotic formulations could form the basis of a new naturally sourced adjunctive approach to cancer chemotherapy.</p>
</abstract>
<kwd-group>
<kwd>mucositis</kwd>
<kwd>probiotics</kwd>
<kwd>probiotic-derived factors</kwd>
<kwd>plant extracts</kwd>
<kwd>chemotherapy</kwd>
<kwd>cancer</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-2156587213477864">
<title>Cancer and Mucositis</title>
<p>Cancer is medically known as a malignant neoplasm that results from abnormal unregulated cell growth.<sup><xref ref-type="bibr" rid="bibr1-2156587213477864">1</xref></sup> These transformed cells can metastasize to the surrounding uninvolved tissues via the lymphatic system or bloodstream.<sup><xref ref-type="bibr" rid="bibr2-2156587213477864">2</xref></sup> Cancer types include bladder cancer,<sup><xref ref-type="bibr" rid="bibr3-2156587213477864">3</xref></sup> lung cancer,<sup><xref ref-type="bibr" rid="bibr4-2156587213477864">4</xref></sup> breast cancer,<sup><xref ref-type="bibr" rid="bibr5-2156587213477864">5</xref></sup> colon and rectal cancer,<sup><xref ref-type="bibr" rid="bibr6-2156587213477864">6</xref></sup> non-Hodgkin lymphoma,<sup><xref ref-type="bibr" rid="bibr7-2156587213477864">7</xref></sup> endometrial cancer,<sup><xref ref-type="bibr" rid="bibr8-2156587213477864">8</xref></sup> pancreatic cancer,<sup><xref ref-type="bibr" rid="bibr9-2156587213477864">9</xref></sup> kidney cancer,<sup><xref ref-type="bibr" rid="bibr10-2156587213477864">10</xref></sup> prostate cancer,<sup><xref ref-type="bibr" rid="bibr11-2156587213477864">11</xref></sup> leukemia,<sup><xref ref-type="bibr" rid="bibr12-2156587213477864">12</xref></sup> and thyroid cancer.<sup><xref ref-type="bibr" rid="bibr13-2156587213477864">13</xref></sup>
</p>
<p>Treatment approaches for malignancies include surgery, chemotherapy, radiation therapy, immunotherapy, and monoclonal antibody therapy.<sup><xref ref-type="bibr" rid="bibr14-2156587213477864">14</xref><xref ref-type="bibr" rid="bibr15-2156587213477864"/>–<xref ref-type="bibr" rid="bibr16-2156587213477864">16</xref></sup> Chemotherapy is employed widely in cancer management.<sup><xref ref-type="bibr" rid="bibr17-2156587213477864">17</xref></sup> However, its effectiveness is often limited by its toxicity to other normal, healthy cells and tissues.<sup><xref ref-type="bibr" rid="bibr17-2156587213477864">17</xref></sup> The toxicity to the digestive tract is termed mucositis.</p>
<sec id="section2-2156587213477864">
<title>Mucositis</title>
<p>Chemotherapy drugs are used to limit the proliferation of tumor cells. However, these drugs coincidentally impair populations of normal cells such as enterocytes.<sup><xref ref-type="bibr" rid="bibr18-2156587213477864">18</xref></sup> Mucositis is a common side-effect of cancer chemotherapy. It causes painful inflammation and ulceration of the mucous membranes lining the digestive tract.<sup><xref ref-type="bibr" rid="bibr19-2156587213477864">19</xref></sup> The term <italic>alimentary mucositis</italic> describes the damage that occurs along the entire gastrointestinal tract. Mucositis can also affect the mouth, referred to as oral mucositis.<sup><xref ref-type="bibr" rid="bibr19-2156587213477864">19</xref>,<xref ref-type="bibr" rid="bibr20-2156587213477864">20</xref></sup> The current review focuses mainly on gastrointestinal mucositis.</p>
<p>A significant number of patients undergoing chemotherapy (40% to 100%) experience different stages of mucositis, depending on the dose and types of chemotherapeutic agent employed.<sup><xref ref-type="bibr" rid="bibr21-2156587213477864">21</xref>,<xref ref-type="bibr" rid="bibr22-2156587213477864">22</xref></sup>
</p>
<p>Intestinal damage caused by chemotherapy can manifest in several ways. For example, chemotherapy has been reported to trigger the death of normal rapidly dividing cells, especially those lining the gastrointestinal tract.<sup><xref ref-type="bibr" rid="bibr23-2156587213477864">23</xref></sup> Chemotherapy has also been demonstrated to change the gut microbiota communities in human individuals and intestinal mucin levels in rats.<sup><xref ref-type="bibr" rid="bibr23-2156587213477864">23</xref>,<xref ref-type="bibr" rid="bibr24-2156587213477864">24</xref></sup> This damage is responsible for breaches to the intestinal barrier, accompanied by increases in intestinal permeability in cancer patients undergoing chemotherapy.<sup><xref ref-type="bibr" rid="bibr25-2156587213477864">25</xref></sup> Subsequently, chemotherapy-induced intestinal impairment provides a conduit for entry of pathogenic bacteria into the systemic circulation, with pro-inflammatory cytokine release and associated inflammation.<sup><xref ref-type="bibr" rid="bibr20-2156587213477864">20</xref></sup> In addition, oxidative stress contributes to further intestinal injury.<sup><xref ref-type="bibr" rid="bibr26-2156587213477864">26</xref></sup> Considered together, damage induced by chemotherapy may lead to intestinal dysfunction, inflammation, and an impaired immune system.<sup><xref ref-type="bibr" rid="bibr22-2156587213477864">22</xref>,<xref ref-type="bibr" rid="bibr23-2156587213477864">23</xref></sup>
</p>
<p>Cancer patients undergoing chemotherapy usually experience symptoms that include abdominal distension, nausea, dysphagia, loss of taste, reduced oral intake, weight loss, and malnutrition.<sup><xref ref-type="bibr" rid="bibr22-2156587213477864">22</xref>,<xref ref-type="bibr" rid="bibr27-2156587213477864">27</xref></sup> Moreover, patients can also experience diarrhea caused by electrolyte imbalance, bleeding from intestinal ulcerations, and bacterial sepsis.<sup><xref ref-type="bibr" rid="bibr22-2156587213477864">22</xref>,<xref ref-type="bibr" rid="bibr28-2156587213477864">28</xref></sup> Indeed, death may even occur.<sup><xref ref-type="bibr" rid="bibr22-2156587213477864">22</xref></sup>
</p>
</sec>
<sec id="section3-2156587213477864">
<title>Pathogenesis of Mucositis</title>
<p>To reduce the severity of mucositis, it is important to understand the pathophysiology of this condition. Sonis<sup><xref ref-type="bibr" rid="bibr29-2156587213477864">29</xref></sup> in 2004 summarized the 5 stages of chemotherapy-induced mucositis. Briefly, the first stage is an “initiation phase,” associated with an increased level of reactive oxygen species and DNA damage to intestinal cells and tissues. The second stage is the “upregulation and message generation phase” characterized by the production of cell transcription factors such as nuclear factor κ-light-chain-enhancer of activated B cells. Together with apoptosis, the mucosa becomes more friable and the patient begins to feel pain. The third stage is the “signaling and amplification phase.” During this stage, levels of tumor necrosis factor-α are increased, together with increased levels of nuclear factor κ-light-chain-enhancer of activated B cells, resulting in further cell apoptosis and tissue injury beneath the mucosal surface. This is followed by the “ulceration and inflammation phase,” which is associated with bacterial colonization and the production of pro-inflammatory cytokines such as interleukin-1 and tumor necrosis factor-α. Together this can result in bacteremia, sepsis, and breached mucosa integrity. The final stage is a healing phase, whereby the intestinal epithelium begins to recover and the normal homeostasis is restored in the gut microbiota.<sup><xref ref-type="bibr" rid="bibr29-2156587213477864">29</xref></sup>
</p>
</sec>
<sec id="section4-2156587213477864">
<title>Treatment of Mucositis</title>
<p>Interest in studying oral mucositis has grown steadily<sup><xref ref-type="bibr" rid="bibr27-2156587213477864">27</xref>,<xref ref-type="bibr" rid="bibr30-2156587213477864">30</xref></sup>; however, in contrast, research into treatments for gastrointestinal mucositis has received less attention. To date, treatment approaches for gastrointestinal mucositis have mainly focused on the identification of agents with the potential to protect the mucosa and promote the repair process, without compromising the cytotoxic effects of chemotherapy. Several growth factors such as milk growth factors and insulin-like growth factor-I<sup><xref ref-type="bibr" rid="bibr28-2156587213477864">28</xref>,<xref ref-type="bibr" rid="bibr31-2156587213477864">31</xref>,<xref ref-type="bibr" rid="bibr32-2156587213477864">32</xref></sup> have exhibited the potential to promote differentiation and proliferation of epithelial cells affected by chemotherapy. Moreover, new nutraceuticals have recently been tested in experimental models for their effects against mucositis. These include probiotic preparations such as VSL#3,<sup><xref ref-type="bibr" rid="bibr33-2156587213477864">33</xref></sup> <italic>Streptococcus thermophilus</italic>,<sup><xref ref-type="bibr" rid="bibr34-2156587213477864">34</xref></sup> <italic>Lactobacillus</italic> spp., and <italic>Escherichia coli </italic>Nissle 1917<sup><xref ref-type="bibr" rid="bibr35-2156587213477864">35</xref></sup> together with prebiotics such as fructo-oligosaccharide.<sup><xref ref-type="bibr" rid="bibr36-2156587213477864">36</xref></sup> Moreover, recently, probiotic-derived factors have begun to show promise at preventing mucositis in vivo and in vitro.<sup><xref ref-type="bibr" rid="bibr35-2156587213477864">35</xref>,<xref ref-type="bibr" rid="bibr37-2156587213477864">37</xref></sup> In addition, there are now early indications that antioxidant and anti-inflammatory constituents in plant extracts, such as Iberogast<sup><xref ref-type="bibr" rid="bibr38-2156587213477864">38</xref></sup> and grape seed extract,<sup><xref ref-type="bibr" rid="bibr39-2156587213477864">39</xref></sup> and animal-sourced oils, such as Lyprinol<sup><xref ref-type="bibr" rid="bibr40-2156587213477864">40</xref></sup> and Emu oil,<sup><xref ref-type="bibr" rid="bibr41-2156587213477864">41</xref></sup> could have utility in preventing mucositis.</p>
<p>In this review, certain probiotic strains, probiotic-derived factors, and plant extracts will be explored for their potential to ameliorate mucositis. The different nature and origins of these agents would suggest that the severity of mucositis could be reduced through different pathways. Thus, the strategy of using strategically defined combinations of these nutraceuticals, such as combinations of probiotics/probiotic-derived factors and plant extracts, could be more effective than the individual agents in protection from mucositis.</p>
</sec>
</sec>
<sec id="section5-2156587213477864">
<title>Probiotics and Mucositis</title>
<p>Probiotics are living microorganisms that, when administered in a sufficient amount, confer health benefits to the host.<sup><xref ref-type="bibr" rid="bibr42-2156587213477864">42</xref></sup> <italic>Lactobacillus</italic> and <italic>bifidobacterium</italic> genera have been found to be the most effective probiotics. <italic>Lactococcus</italic>, <italic>streptococcus</italic>, and <italic>enterococcus</italic> species, as well as some nonpathogenic strains of <italic>Escherichia coli</italic> and some bacilli and yeast strains, may also meet this definition.<sup><xref ref-type="bibr" rid="bibr43-2156587213477864">43</xref></sup>
</p>
<p>The beneficial properties of probiotics have been studied over decades. It is believed that probiotics have the potential to maintain a healthy gut microbiota, and most importantly reduce the severity of certain disorders, which include gastrointestinal diseases such as inflammatory bowel disease, diabetes, and atopic diseases.<sup><xref ref-type="bibr" rid="bibr44-2156587213477864">44</xref><xref ref-type="bibr" rid="bibr45-2156587213477864"/>–<xref ref-type="bibr" rid="bibr46-2156587213477864">46</xref></sup> Indeed, <italic>Escherichia coli</italic> Nissle 1917 has been prescribed widely for the treatment of inflammatory bowel disease in some countries, including Germany.<sup><xref ref-type="bibr" rid="bibr47-2156587213477864">47</xref></sup>
</p>
<p>The mechanisms of probiotic action have been summarized by Howarth in 2010.<sup><xref ref-type="bibr" rid="bibr48-2156587213477864">48</xref></sup> Briefly, certain probiotics have the ability to adhere to the intestinal–lumen interface, compete with pathogens for nutrients and binding sites, enhance mucosal barrier function, modulate cell kinetics by adjusting the proliferation to apoptosis ratio, and promote innate and adaptive immune responses. Based on these features, it is possible to speculate that probiotics, especially some newfound probiotic strains, could hold the potential to reduce gut damage from chemotherapy administration.</p>
<p>Prisciandaro et al reviewed evidence supporting the use of probiotics for the potential prevention and treatment of chemotherapy-induced mucositis.<sup><xref ref-type="bibr" rid="bibr49-2156587213477864">49</xref></sup> The current review extends this strategy to include recently identified probiotics and the added potential for these bacteria to be more effective when administered in combination with certain antioxidant plant extracts.</p>
<sec id="section6-2156587213477864">
<title>Competition With Pathogens for Binding Sites</title>
<p>It has been reported that mucin binding proteins can be identified from probiotics such as <italic>Bifidobacteria bifidium</italic> species and <italic>Lactococcus lactis</italic> ssp. lactis BGKP1, contributing to binding properties in vivo and in vitro.<sup><xref ref-type="bibr" rid="bibr50-2156587213477864">50</xref>,<xref ref-type="bibr" rid="bibr51-2156587213477864">51</xref></sup> In addition, a few <italic>Lactobacillus </italic>spp. and <italic>Bifidobacterium </italic>spp. were found to inhibit the growth of certain intestinal pathogens, including <italic>Escherichia coli</italic> and <italic>Salmonella</italic> spp., in laboratory experiments.<sup><xref ref-type="bibr" rid="bibr52-2156587213477864">52</xref>,<xref ref-type="bibr" rid="bibr53-2156587213477864">53</xref></sup> Probiotics may therefore compete with pathogens for binding sites and nutrients, potentially decreasing the likelihood of pathogen infection and secondary infections associated with chemotherapy.</p>
</sec>
<sec id="section7-2156587213477864">
<title>Probiotic Versus Microbiota</title>
<p>Chemotherapy tends to alter the composition of the microbiota toward a more pathogenic community. For example, decreases of <italic>Clostridium</italic> spp., <italic>Lactobacillus</italic> spp., and <italic>Streptococcus</italic> spp. and an increase in <italic>Escherichia</italic> spp. were found in the jejunum of 5-fluorouracil-injected rats.<sup><xref ref-type="bibr" rid="bibr24-2156587213477864">24</xref></sup> Administration of probiotics (<italic>Bifidobacteria</italic> and <italic>Lactobacillus</italic>), for 7 days after elective laparoscopic radical surgery for colorectal cancer, significantly modified the fecal microbiota by increasing numbers of <italic>Bifidobacterium</italic>, <italic>Lactobacillus</italic>, and <italic>Enterococcus</italic> and decreasing <italic>Escherichia coli</italic> and <italic>Staphylococcus aureus</italic>.<sup><xref ref-type="bibr" rid="bibr54-2156587213477864">54</xref></sup> Thus, certain probiotics could potentially restore and normalize the chemotherapy-affected gut microbiota.</p>
</sec>
<sec id="section8-2156587213477864">
<title>Maintenance of the Gut Barrier</title>
<p>Breach of the intestinal barrier has always been a serious issue for cancer patients undergoing chemotherapy.<sup><xref ref-type="bibr" rid="bibr25-2156587213477864">25</xref></sup> Disturbed mucin secretion, goblet cell production, and enterocyte tight junction proteins amplify the risk of bacterial infection and translocation into surrounding tissues.<sup><xref ref-type="bibr" rid="bibr24-2156587213477864">24</xref>,<xref ref-type="bibr" rid="bibr29-2156587213477864">29</xref></sup> Some probiotic strains such as <italic>Lactobacillus plantarum</italic> spp., and the probiotic mixture VSL#3, have demonstrated capacities to modulate tight junction proteins such as occludin, zonula, occludens-1, claudin-1, claudin-2, claudin-4, junction adhesion molecule-A, and F-actin, which are important in building the physical connections between epithelial cells for normal gut permeability.<sup><xref ref-type="bibr" rid="bibr55-2156587213477864">55</xref><xref ref-type="bibr" rid="bibr56-2156587213477864"/>–<xref ref-type="bibr" rid="bibr57-2156587213477864">57</xref></sup> VSL#3 increased expression of the epithelial tight junction protein, occludin, and downregulated expression of claudin-2, which attenuated increased gut permeability in mice with experimentally induced Crohn’s disease.<sup><xref ref-type="bibr" rid="bibr55-2156587213477864">55</xref></sup> Moreover, certain probiotics have the ability to maintain intestinal mucin levels, which may be influenced by chemotherapy.</p>
<p>The capacity for probiotic strains such as <italic>Lactobacillus </italic>spp. and <italic>Clostridium tyrobutyricum</italic> to adjust mucin secretion could therefore play a pivotal role in restoring microbiota composition and mucosal immunity in chemotherapy-treated patients.<sup><xref ref-type="bibr" rid="bibr58-2156587213477864">58</xref>
<xref ref-type="bibr" rid="bibr59-2156587213477864"/>–<xref ref-type="bibr" rid="bibr60-2156587213477864">60</xref></sup> Furthermore, certain probiotics have the potential to modulate cell kinetics by adjusting homeostasis between apoptosis and proliferation. For example, <italic>Lactobacillus rhamnosus</italic> regulated cellular proliferation and migration and mitogen-activated protein kinase pathways, responsible for cell proliferation, differentiation, and cytoprotection.<sup><xref ref-type="bibr" rid="bibr61-2156587213477864">61</xref>,<xref ref-type="bibr" rid="bibr62-2156587213477864">62</xref></sup> In contrast, some other probiotic mixtures such as kefir were found to reduce the incidence of apoptosis in heart tissues by controlling the activities of pro-apoptotic proteins such as Bax, bad, cytochrome c, and caspase-3 in ovalbumin-treated rats.<sup><xref ref-type="bibr" rid="bibr63-2156587213477864">63</xref></sup> Considered together, an imbalance in the ratio of enterocyte apoptosis to proliferation, induced by chemotherapy, could potentially be restored by the intake of certain probiotics.</p>
</sec>
<sec id="section9-2156587213477864">
<title>Probiotics and Immunity</title>
<p>Administration of certain probiotics can enhance innate immunity by increasing numbers and activities of immune cells and mediating inflammation.<sup><xref ref-type="bibr" rid="bibr45-2156587213477864">45</xref></sup> In addition, probiotics may improve adaptive immune function by modulation of antigen-specific antibodies.<sup><xref ref-type="bibr" rid="bibr54-2156587213477864">54</xref></sup> For example, numbers of circulating natural killer cells and immature T cell subsets increased in elderly individuals ingesting <italic>Lactobacillus delbrueckii</italic> subsp. <italic>bulgaricus</italic> 8481 for 6 months.<sup><xref ref-type="bibr" rid="bibr45-2156587213477864">45</xref></sup> Moreover, the immune risk phenotype, characterized by an inverted CD4/CD8 ratio, an increase of CD8+CD28<sup>null</sup> T cells, and cytomegalovirus infection was also amplified in the same study.<sup><xref ref-type="bibr" rid="bibr45-2156587213477864">45</xref>,<xref ref-type="bibr" rid="bibr64-2156587213477864">64</xref></sup> Furthermore, administration of <italic>Clostridium tyrobutyricum</italic> depressed expression of pro-inflammatory cytokines such as tumor necrosis factor-α and interleukin-18 in the descending colon of dextran sodium sulfate–treated mice.<sup><xref ref-type="bibr" rid="bibr59-2156587213477864">59</xref></sup> Similar results have also been described in cytokine-mediated gastrointestinal diseases,<sup><xref ref-type="bibr" rid="bibr65-2156587213477864">65</xref></sup> alcohol-induced inflammation,<sup><xref ref-type="bibr" rid="bibr66-2156587213477864">66</xref>,<xref ref-type="bibr" rid="bibr67-2156587213477864">67</xref></sup> and even chemotherapy-induced mucositis.<sup><xref ref-type="bibr" rid="bibr34-2156587213477864">34</xref></sup> Besides, administration of probiotics (Jinshuangqi tablets) for 7 days significantly improved levels of IgA, IgG, IgM, interelukin-2, and CD4+ in the serum of colorectal cancer patients, demonstrating the capacity for probiotics to modulate adaptive immunity.<sup><xref ref-type="bibr" rid="bibr54-2156587213477864">54</xref></sup>
</p>
</sec>
</sec>
<sec id="section10-2156587213477864">
<title>Probiotic-Derived Factors</title>
<p>Probiotic-derived factors are proteins or other molecules released from living probiotics, with the potential to confer health benefits to the host. Investigation of these factors could be used to achieve therapeutic benefits while avoiding risks related to the administration of live bacteria.<sup><xref ref-type="bibr" rid="bibr48-2156587213477864">48</xref></sup> Identification of specific probiotic-derived factors also provides an opportunity to better understand mechanisms of probiotic action.</p>
<sec id="section11-2156587213477864">
<title>Competition With Pathogens</title>
<p>Bacteriocins, such as reuterin and other proteinaceous molecules, have been shown to inhibit the adhesion and viability of known enteric pathogens.<sup><xref ref-type="bibr" rid="bibr48-2156587213477864">48</xref>,<xref ref-type="bibr" rid="bibr68-2156587213477864">68</xref></sup> <italic>Lactobacillus acidophilus</italic> ATCC 4356 releases a proteinaceous molecule that inhibited the activity of 8 of the human <italic>Campylobacter jejuni</italic> strains affecting Caco-2 cells.<sup><xref ref-type="bibr" rid="bibr69-2156587213477864">69</xref></sup> Moreover, other strains of <italic>Lactobacillus </italic>spp. produced non–lactic acid molecules in their cell-free cultured supernatants, which were responsible for killing activity against pathogenic <italic>Salmonella enterica</italic> serovar Typhimurium SL1344.<sup><xref ref-type="bibr" rid="bibr70-2156587213477864">70</xref>,<xref ref-type="bibr" rid="bibr71-2156587213477864">71</xref></sup> Together, these probiotic-derived factors both restricted the activity and killed certain pathogens, thereby decreasing the likelihood of infection, potentially reducing bacterial invasion caused by chemotherapy.</p>
</sec>
<sec id="section12-2156587213477864">
<title>Maintenance of the Gut Barrier</title>
<p>Modulation of the mucus layer, tight junctions, and gut permeability by probiotic-derived factors play an important role in the maintenance of gut integrity. These factors could therefore potentially ameliorate the gut damage induced by chemotherapy.<sup><xref ref-type="bibr" rid="bibr48-2156587213477864">48</xref></sup> Administration of <italic>Lactobacillus rhamnosus</italic> supernatants to alcohol-treated mice altered intestinal tight junction proteins by increasing ileum mRNA levels of claudin-1.<sup><xref ref-type="bibr" rid="bibr67-2156587213477864">67</xref></sup> Moreover, mRNA levels of intestinal trefoil factor, P-glycoprotein, and cathelin-related antimicrobial peptide were also restored by <italic>Lactobacillus rhamnosus</italic> supernatant pretreatment.<sup><xref ref-type="bibr" rid="bibr67-2156587213477864">67</xref></sup> In addition, <italic>Lactobacillus rhamnosus</italic> supernatants prevented barrier dysfunction of Caco-2 cell monolayers, induced by alcohol.<sup><xref ref-type="bibr" rid="bibr72-2156587213477864">72</xref></sup> Certain proteinaceous factors extracted from <italic>Clostridium butyridium</italic> CGMCC0313-1 have been reported to augment the expression of A20 in HT-29 cells, which is important in the maintenance of barrier function.<sup><xref ref-type="bibr" rid="bibr73-2156587213477864">73</xref></sup> Together, these in vitro results demonstrate the potential for probiotic-derived factors to maintain the intestinal barrier following chemotherapy-induced gut damage in vivo and in vitro.</p>
</sec>
<sec id="section13-2156587213477864">
<title>Cell Kinetics</title>
<p>Two novel proteins, p75 (75 kDa) and p40 (40 kDa), released from <italic>Lactobacillus rhamnosus</italic>, have been reported to promote the propagation of epithelial cells and prevent apoptosis of epithelial cells induced by tumor necrosis factor-α.<sup><xref ref-type="bibr" rid="bibr65-2156587213477864">65</xref></sup> Moreover, a recent study by Lebeer et al found that p75, renamed as Msp1, secreted by <italic>Lactobacillus rhamnosus</italic>, is an <italic>O</italic>-glycosylated protein.<sup><xref ref-type="bibr" rid="bibr74-2156587213477864">74</xref></sup> Glycosylation of Msp1 plays an important role in communication between the microbe and the host.<sup><xref ref-type="bibr" rid="bibr74-2156587213477864">74</xref></sup> In addition, Prisciandaro et al recently reported that supernatants from <italic>Lactobacillus rhamnosus</italic> and <italic>Escherichia coli </italic>Nissle 1917 significantly decreased caspase 3/7 activity after a challenge by the chemotherapy antimetabolite, 5-fluorouracil, in the IEC-6 cell line, showing their potential ability to prevent or inhibit enterocyte apoptosis induced by chemotherapy.<sup><xref ref-type="bibr" rid="bibr35-2156587213477864">35</xref></sup>
</p>
</sec>
<sec id="section14-2156587213477864">
<title>Immunity</title>
<p>Probiotic-derived factors have been shown to influence pathogen-induced or oxidative stimuli–induced inflammation. Several metabolites (&lt;3000 Da), released from <italic>Bifidobacterium breve</italic> and <italic>Streptococcus thermophilus</italic>, have demonstrated the ability to inhibit tumor necrosis factor-α secretion from lipopolysaccharide-affected peripheral blood mononuclear cells or the THP-1 cell line.<sup><xref ref-type="bibr" rid="bibr75-2156587213477864">75</xref></sup> In addition, these factors (metabolites) were reported to suppress lipopolysaccharide-FITC (a fluorescent marker by flow cytometry) binding to THP-1 cells and also to inhibit nuclear factor-κB activation. Moreover, <italic>Lactobacillus reuteri</italic>–formed biofilms have been shown to decrease tumor necrosis factor production in lipopolysaccharide-activated monocytoid cells.<sup><xref ref-type="bibr" rid="bibr76-2156587213477864">76</xref></sup> Caco-2 cells pretreated with spent culture supernatants of <italic>Lactobacillus plantarum</italic> 2142 for 1 hour decreased interleukin-8 synthesis and, in addition, induced expression of Heat-shock protein (Hsp) 70.<sup><xref ref-type="bibr" rid="bibr77-2156587213477864">77</xref></sup> More recently, probiotic <italic>Lactobacillus paracasei</italic> CNCM I-4034 cell-free supernatants reduced pro-inflammatory tumor necrosis factor-α and chemokine MCP-1 in human dendritic cells challenged with enteropathogenic <italic>Salmonella</italic>.<sup><xref ref-type="bibr" rid="bibr78-2156587213477864">78</xref></sup> Interestingly, these supernatants produced similar beneficial effects to their living “parent” probiotic, <italic>Lactobacillus paracasei</italic> CNCM I-4034.</p>
<p>Probiotic-derived factors from <italic>Bifidobacterium bifidum</italic> LMG13195 could be a potential immunoregulator in vitro. These soluble factors, after being previously cocultured with HT29 cells, enhanced numbers of CD4<sup>+</sup>CD25<sup>high</sup> cells expressing chemokine receptor Treg markers in human peripheral blood mononuclear cells.<sup><xref ref-type="bibr" rid="bibr79-2156587213477864">79</xref></sup> Probiotic-derived factors could therefore exert similar effects to their parent probiotic counterparts by modulating immune cells to reduce inflammation and restore immunity affected by chemotherapy.</p>
</sec>
</sec>
<sec id="section15-2156587213477864">
<title>Prebiotics</title>
<p>Prebiotics are indigestible compounds that “selectively stimulate the growth and/or activity of microbial species in the gut microbiota and confer health benefits to the host.”<sup><xref ref-type="bibr" rid="bibr80-2156587213477864">80</xref></sup> Prebiotics must be neither hydrolyzed nor absorbed in the proximal gastrointestinal tract, must be selectively fermented by one or a limited number of beneficial bacteria in the intestine, and be able to alter the colonic microbiota toward a healthier composition.<sup><xref ref-type="bibr" rid="bibr80-2156587213477864">80</xref>,<xref ref-type="bibr" rid="bibr81-2156587213477864">81</xref></sup> Prebiotic compounds include inulin,<sup><xref ref-type="bibr" rid="bibr82-2156587213477864">82</xref></sup> a plant derived fructan; lactulose<sup><xref ref-type="bibr" rid="bibr83-2156587213477864">83</xref></sup>; galacto-oligosaccharide<sup><xref ref-type="bibr" rid="bibr84-2156587213477864">84</xref></sup>; and fructo-oligosaccharide.<sup><xref ref-type="bibr" rid="bibr85-2156587213477864">85</xref></sup> Other compounds studied for their prebiotic potential include arabinoxylan-oligosaccharides,<sup><xref ref-type="bibr" rid="bibr86-2156587213477864">86</xref></sup> chito-oligosaccharides,<sup><xref ref-type="bibr" rid="bibr87-2156587213477864">87</xref></sup> epilactose,<sup><xref ref-type="bibr" rid="bibr88-2156587213477864">88</xref></sup> germinated barley foodstuff,<sup><xref ref-type="bibr" rid="bibr89-2156587213477864">89</xref></sup> mannan-oligosaccharides,<sup><xref ref-type="bibr" rid="bibr90-2156587213477864">90</xref></sup> sialyl-oligosaccharides,<sup><xref ref-type="bibr" rid="bibr91-2156587213477864">91</xref></sup> xylo-oligosaccharides,<sup><xref ref-type="bibr" rid="bibr92-2156587213477864">92</xref></sup> and β-1,4-mannobiose.<sup><xref ref-type="bibr" rid="bibr93-2156587213477864">93</xref></sup>
</p>
<p>The potential role of prebiotics in mucositis treatment has recently (2012) been reviewed comprehensively by Wang et al.<sup><xref ref-type="bibr" rid="bibr94-2156587213477864">94</xref></sup> Briefly, prebiotics have the ability to modulate probiotic bacteria by selective colonization of the intestinal microbiota, thereby decreasing chemotherapy-induced intestinal dysbiosis. Prebiotics could therefore maintain homeostasis of the gut microbiota following induction of mucositis. Moreover, certain prebiotics play an important role in the digestion and absorption of nutrients in the gut<sup><xref ref-type="bibr" rid="bibr95-2156587213477864">95</xref></sup> and modulate intestinal barrier function through effects on mucin expression<sup><xref ref-type="bibr" rid="bibr96-2156587213477864">96</xref></sup> and modification of mucosal immune responses.<sup><xref ref-type="bibr" rid="bibr97-2156587213477864">97</xref></sup> Prebiotics could therefore become new nutraceuticals in terms of the amelioration of mucositis. Howarth recently proposed the importance of inflammasomes in mediating inflammation by prebiotics. However, further studies are required to determine the underlying mechanism of prebiotic action in the prevention and/or treatment of mucositis.<sup><xref ref-type="bibr" rid="bibr98-2156587213477864">98</xref></sup>
</p>
</sec>
<sec id="section16-2156587213477864">
<title>Plant Extracts and Their Active Constituents</title>
<p>Many natural plant extracts have demonstrated medicinal uses at inhibiting the viability of pathogens.<sup><xref ref-type="bibr" rid="bibr99-2156587213477864">99</xref></sup> These include Cat’s claw (<italic>Uncaria tomentosa</italic>), Maca (<italic>Lepidium meyenii</italic>), and Dragon’s blood (<italic>Croton lechleri</italic>). However, in this review, we focus on the potential of readily accessible plant extracts, such as grape seed extract and Iberogast (and their commonly shared active constituents), to reduce the severity of gastrointestinal mucositis.</p>
<p>Phenolic compounds or polyphenols are widely distributed in the plant regime.<sup><xref ref-type="bibr" rid="bibr100-2156587213477864">100</xref></sup> They are characterized by the presence of multiple phenol structures. Flavonoids are one type of phenolic compounds, which can be classified into flavonols, flavanols, and many others. Flavonol comprises a ketone group (RC(=O)R′); flavanol or flavan-3-ols (catechins) belong to the flavonoid classification and are structurally similar to flavonol, but they are in the non-ketone group (<xref ref-type="table" rid="table1-2156587213477864">Table 1</xref>).<sup><xref ref-type="bibr" rid="bibr101-2156587213477864">101</xref></sup>
</p>
<table-wrap id="table1-2156587213477864" position="float">
<label>Table 1.</label>
<caption>
<p>Classification and Chemical Structure of Phenolic Compounds.</p>
</caption>
<graphic alternate-form-of="table1-2156587213477864" xlink:href="10.1177_2156587213477864-table1.tif"/>
<table>
<thead>
<tr>
<th>Classification</th>
<th>Chemical Structure</th>
</tr>
</thead>
<tbody>
<tr>
<td>Plant</td>
<td>Example</td>
</tr>
<tr>
<td>Phenolic compounds</td>
<td>
<inline-graphic xlink:href="10.1177_2156587213477864-fig1.tif"/> (Simple phenols)</td>
</tr>
<tr>
<td>Flavonoids and many others</td>
<td>
<inline-graphic xlink:href="10.1177_2156587213477864-fig2.tif"/> (Flavonoids)</td>
</tr>
<tr>
<td>Flavonols (ketone group)</td>
<td>
<inline-graphic xlink:href="10.1177_2156587213477864-fig3.tif"/> (Flavonols; ketone group)</td>
</tr>
<tr>
<td>Flavanols (non-ketone group)</td>
<td>
<inline-graphic xlink:href="10.1177_2156587213477864-fig4.tif"/> (Flavanols; non-ketone group)</td>
</tr>
<tr>
<td>Proanthocyanidins (high-molecular-weight polymers)</td>
<td>
<inline-graphic xlink:href="10.1177_2156587213477864-fig5.tif"/> (Proanthocyannidins)</td>
</tr>
<tr>
<td align="center" colspan="2">Free radical scavenging</td>
</tr>
<tr>
<td align="center" colspan="2">Antioxidant</td>
</tr>
<tr>
<td align="center" colspan="2">Antibacterial and antiviral</td>
</tr>
<tr>
<td align="center" colspan="2">Anti-inflammatory</td>
</tr>
<tr>
<td align="center" colspan="2">Anti-carcinogenic</td>
</tr>
<tr>
<td align="center" colspan="2">Anti-allergenic</td>
</tr>
<tr>
<td align="center" colspan="2">Vasodilatory</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-2156587213477864">
<p>Adapted from Fine AM. Oligomeric proanthocyanidin complexes: history, structure, and phytopharmaceutical applications. <italic>Altern Med Rev</italic>. 2000;5:144-151.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>In chemical structure, single-molecule flavan-3-ol adds hydroxyls (–OH) becoming catechin or its isomer, epicatechin. Procyanidins, members of the proanthocyanidins, are concentrated polymers formed from the monomers catechin and epicatechin.<sup><xref ref-type="bibr" rid="bibr102-2156587213477864">102</xref></sup> Therefore, catechin trimers become oligomeric proanthocyanidin complexes and higher order polymers become anthocyanidins (<xref ref-type="table" rid="table1-2156587213477864">Table 1</xref>).<sup><xref ref-type="bibr" rid="bibr102-2156587213477864">102</xref></sup>
</p>
<p>The most significant effect of procyanidins/proanthocyanidins is that they possess reactive oxygen species free radical scavenging ability. This results from antioxidant activities in many plant-sourced extracts including grape seed extract, Cat’s Claw, Maca, and Dragon’s Blood.<sup><xref ref-type="bibr" rid="bibr103-2156587213477864">103</xref><xref ref-type="bibr" rid="bibr104-2156587213477864"/><xref ref-type="bibr" rid="bibr105-2156587213477864"/>–<xref ref-type="bibr" rid="bibr106-2156587213477864">106</xref></sup> The antioxidant ability of plant extracts against reactive oxygen species is elucidated in the following sections.</p>
<sec id="section17-2156587213477864">
<title>Effects of Active Constituents of Plant Extracts on Reactive Oxygen Species</title>
<p>Reactive oxygen species are chemically reactive molecules (free radicals) containing oxygen such as oxygen ions and peroxides. Oxidative stress plays an important role in the pathogenesis of disorders, which include rheumatoid arthritis, asthma, psoriasis, and contact dermatitis.<sup><xref ref-type="bibr" rid="bibr105-2156587213477864">105</xref></sup> Chemotherapy generates reactive oxygen species, which can initiate a series of biological actions.<sup><xref ref-type="bibr" rid="bibr29-2156587213477864">29</xref></sup> For example, reactive oxygen species induce neutrophil infiltration and pro-inflammatory cytokine production, such as tumor necrosis factor-α. Increased tumor necrosis factor-α in the submucosa activates and amplifies transcription factors such as nuclear factor-κB. This is thought to induce cell apoptosis, leading to breakdown of the intestinal epithelial monolayer, intestinal barrier damage, pathogen invasion, and clinical manifestations of mucositis.<sup><xref ref-type="bibr" rid="bibr29-2156587213477864">29</xref>,<xref ref-type="bibr" rid="bibr107-2156587213477864">107</xref>,<xref ref-type="bibr" rid="bibr108-2156587213477864">108</xref></sup> Furthermore, reactive oxygen species potentially reacts with macromolecules of the gut mucosa, such as lipids, proteins, and nucleic acid, and causes lipid peroxidation, which has a role in destruction of the intestinal epithelium.<sup><xref ref-type="bibr" rid="bibr39-2156587213477864">39</xref>,<xref ref-type="bibr" rid="bibr109-2156587213477864">109</xref></sup> Therefore, overproduction of reactive oxygen species plays an important role in the pathogenesis of chemotherapy-induced gut damage.</p>
<p>Many studies have reported the antioxidative properties of phenolic compounds. Phenolic substances such as procyanidins interact with the polar head group of phospholipids in cell membranes to exert their antioxidant effects.<sup><xref ref-type="bibr" rid="bibr110-2156587213477864">110</xref></sup> Verstraeten et al<sup><xref ref-type="bibr" rid="bibr111-2156587213477864">111</xref></sup> showed that dimer and trimer procyanidins protected the bilayer from oxidant-induced stress by interacting with membrane phospholipids. Facino et al<sup><xref ref-type="bibr" rid="bibr112-2156587213477864">112</xref></sup> reported that a procyanidin-enriched diet fed to rats was associated with increased antioxidant activity in the plasma and reduced cardiac damage. Similar results were obtained by Busserolles et al,<sup><xref ref-type="bibr" rid="bibr113-2156587213477864">113</xref></sup> who fed rats procyanidin-rich extracts for 8 weeks. Plasma antioxidant capacity was higher in rats than those fed the control diet, indicating the antioxidant effect of plasma procyanidins in vivo.<sup><xref ref-type="bibr" rid="bibr113-2156587213477864">113</xref></sup>
</p>
<p>Malondialdehyde level is a presumptive marker for lipid peroxidation that results from lipid-free radical interaction.<sup><xref ref-type="bibr" rid="bibr106-2156587213477864">106</xref></sup> Kalin et al reported the ability of proanthocyanidins to decrease malondialdehyde levels.<sup><xref ref-type="bibr" rid="bibr106-2156587213477864">106</xref></sup> This has also been demonstrated by Gulgun et al,<sup><xref ref-type="bibr" rid="bibr109-2156587213477864">109</xref></sup> who showed that proanthocyanidins decreased mucosal damage and oxidant stress from the chemotherapy drug methotrexate through decreasing lipid peroxidation. Additionally, proanthocyanidins significantly inhibited toxicity from cancer chemotherapeutic drugs (Idarubicin and 4-hydroxyperoxycyclophosphamide) through increased expression of the anti-apoptotic protein, Bcl-2.<sup><xref ref-type="bibr" rid="bibr114-2156587213477864">114</xref></sup> Furthermore, Kalin et al<sup><xref ref-type="bibr" rid="bibr106-2156587213477864">106</xref></sup> concluded that proanthocyanidins decreased the induction of adhesion molecules such as ICAM-1, VCAM-1, and E-selectin, which are responsible for damage to the vascular endothelium.</p>
<p>Procyanidins/proanthocyanidins also exert anti-inflammatory and anti-ulcerogenic effects.<sup><xref ref-type="bibr" rid="bibr39-2156587213477864">39</xref>,<xref ref-type="bibr" rid="bibr109-2156587213477864">109</xref></sup> Bak et al<sup><xref ref-type="bibr" rid="bibr115-2156587213477864">115</xref></sup> showed that procyanidins from wild grape seeds exhibit a chemopreventive character, due to an increase in nuclear factor E2–related factor expression. Nuclear factor E2–related factor is related to the antioxidant response element, which mediates expression of phase II detoxifying/antioxidant enzymes, such as NAD(P)H: quinone oxidoreductase-1 (NQ01) and heme oxygenase-1 (HO-1). These enzymes play a vital role in cell protection and cancer prevention. Furthermore, it is believed that proanthocyanidins exert an antithrombotic effect and can improve mucosal blood flow, which may contribute to antiulcer effects.<sup><xref ref-type="bibr" rid="bibr109-2156587213477864">109</xref></sup> In an in vivo study, proanthocyanidins exerted antiulcer effects on the gastric mucosa, through significantly inhibiting myeloperoxidase activities (as an inflammatory indicator) and stimulating superoxide dismutase activities (as an antioxidative indicator) in rats.<sup><xref ref-type="bibr" rid="bibr116-2156587213477864">116</xref></sup> It was reported that proanthocyanidin decreased leukocyte infiltration and tumor necrosis factor-α and interleukin-1β (pro-inflammatory factors), CINC-1 (an important mediator that promotes migration of neutrophils), and nitrite levels in the pleural exudation, which occurred after a carrageen-induced acute inflammatory reaction in rats.<sup><xref ref-type="bibr" rid="bibr117-2156587213477864">117</xref></sup> These results further supported the anti-inflammatory effects of proanthocyandins.</p>
<p>In summary, phenolic compounds possess antioxidant, anti-inflammatory, and anti-ulcerogenic properties. These properties of procyanidins/proanthocyanidins are partly contributed by their free-radical scavenging characteristics, modulating apoptotic regulatory genes such as bcl-2 and p53, thereby influencing the production of pro-inflammatory factors such as tumor necrosis factor-α and interleukin-1β.<sup><xref ref-type="bibr" rid="bibr109-2156587213477864">109</xref>,<xref ref-type="bibr" rid="bibr114-2156587213477864">114</xref></sup> Plant extracts, which contain these active constituents, could therefore be of benefit in treating or preventing mucositis.</p>
</sec>
<sec id="section18-2156587213477864">
<title>Plant Extracts and Intestinal Mucositis</title>
<p>Very few studies have tested the effects of plant extracts on mucositis. Cheah et al<sup><xref ref-type="bibr" rid="bibr39-2156587213477864">39</xref></sup> studied the potential for grape seed extract to protect the rat intestine from 5-fluorouracil-induced intestinal damage in vitro and in vivo. These investigators reported that grape seed extract had the ability to restore IEC-6 cell viability following damage by 5-fluorouracil, indicating that grape seed extract was partially effective against this chemotherapy drug in vitro. Additionally, grape seed extract showed the ability to reduce 5-fluorouracil-induced intestinal myeloperoxidase activity, an indicator of inflammation. Furthermore, grape seed extract was found to remain active in the large bowel.<sup><xref ref-type="bibr" rid="bibr39-2156587213477864">39</xref></sup> Moreover, Gulgun et al showed promising results for proanthocyanidins in improving methotrexate-induced intestinal damage in rats.<sup><xref ref-type="bibr" rid="bibr109-2156587213477864">109</xref></sup> Proanthocyanidins reduced methotrexate-induced inflammation and associated ulceration and normalized the activities of superoxide dismutase and glutathione peroxidase. This indicated that proanthocyanidins amplified the defense system against oxidative stress and also decreased lipid peroxidation following methotrexate-induced damage.<sup><xref ref-type="bibr" rid="bibr109-2156587213477864">109</xref></sup>
</p>
<p>Iberogast, also known as STW5, is a mixture of 9 different herbal extracts containing bitter candytuft (<italic>Iberis amara</italic>), angelica root (<italic>Angelicae radix</italic>), milk thistle fruit (<italic>Cardui mariae fructus</italic>), celandine herb (<italic>Chelidonii herba</italic>), caraway fruit (<italic>Carvi fructus</italic>), liquorice root (<italic>Liquiritiae radix</italic>), peppermint herb (<italic>Menthae piperitae folium</italic>), balm leaf (<italic>Melissae folium</italic>), and chamomile flower (<italic>Matricariae flos</italic>).<sup><xref ref-type="bibr" rid="bibr118-2156587213477864">118</xref></sup> Iberogast modulates gastrointestinal motility and restricts gastric acid production. It also possesses anti-inflammatory, antioxidative, and free radical–inhibiting properties. The active compounds in Iberogast, especially flavonoids, are believed to contribute to its pharmacological properties in the therapy of several gastrointestinal conditions such as functional dyspepsia and irritable bowel syndrome.<sup><xref ref-type="bibr" rid="bibr118-2156587213477864">118</xref></sup> Indeed, recently, Iberogast has been tested for its therapeutic efficacies on 5-fluorouracil-induced mucositis in rats.<sup><xref ref-type="bibr" rid="bibr38-2156587213477864">38</xref></sup> Iberogast improved the histopathological features of mucosa, which were damaged by 5-fluorouracil injection. Villus height and crypt depth were increased significantly in Iberogast-fed rats treated with 5-fluorouracil.<sup><xref ref-type="bibr" rid="bibr38-2156587213477864">38</xref></sup> However, other indicators of mucositis were unaffected by Iberogast in 5-fluorouracil-treated rats.<sup><xref ref-type="bibr" rid="bibr38-2156587213477864">38</xref></sup> These results indicate that Iberogast may possess the potential to reduce the severity of chemotherapy-induced mucositis; however, further studies on dose and frequency of administration are warranted.</p>
<p>Other plant extracts such as glycolipid extracts from spinach, which comprise high levels of glycoglycerolipids, have revealed antioxidative and anti-inflammatory effects in the 5-fluorouracil setting in vivo and in vitro. Mucosal injury, such as villous atrophy and misaligned crypts in the jejunum of rats affected by 5-fluorouracil, were ameliorated significantly in rats fed glycolipid extracts.<sup><xref ref-type="bibr" rid="bibr119-2156587213477864">119</xref></sup> Moreover, glycolipid extracts reduced mRNA expression of inflammatory cytokines such as interleukin-1α and tumor necrosis factor-α caused by 5-fluorouracil injection in the same group of rats. In addition, the active constituents of spinach extract, such as monogalactosyl-diacylglycerol and diglactosyl-diacylglycerol, inhibited the production of reactive oxygen species in phorbol ester challenged Caco-2 cells.<sup><xref ref-type="bibr" rid="bibr119-2156587213477864">119</xref></sup> Furthermore, following 5-fluorouracil administration, hamsters fed <italic>Eriobotrya japonica</italic> seed extract showed no epithelial tissue defects or bacterial infections at the local site of mucositis in the oral cavity.<sup><xref ref-type="bibr" rid="bibr120-2156587213477864">120</xref></sup> Plasma lipid peroxide levels were also decreased significantly in the same group.<sup><xref ref-type="bibr" rid="bibr120-2156587213477864">120</xref></sup> Moreover, in a clinical trial, the severity of radi-ation-induced mucositis was attenuated in patients, as measured by significantly decreased serum interleukin-6 levels, following gargling and ingestion of indigowood root (<italic>Isatis indigotica</italic> Fort.).<sup><xref ref-type="bibr" rid="bibr121-2156587213477864">121</xref></sup>
</p>
<p>In summary, certain plant extracts such as grape seed extract and Iberogast have revealed anti-inflammatory and antioxidant effects on chemotherapy-induced mucositis. These plant extracts could be a potential new prophylactic treatment strategy for intestinal mucositis,<sup><xref ref-type="bibr" rid="bibr39-2156587213477864">39</xref></sup> although further research is required. Further studies should focus on identifying the bioactive constituents involved together with the identification of further, as yet untested plant extracts.</p>
</sec>
</sec>
<sec id="section19-2156587213477864">
<title>Combinations of Probiotics/Probiotic-Derived Factors and Plant Extracts</title>
<p>Synbiotics are defined as strategically-identified symbiotic combinations of probiotics and prebiotics. Synbiotics may be exhibit greater potency compared to the sum of each individual agent. Shimizu et al recently elucidated the importance of synbiotics in the maintenance of gut health and treatment of critical illnesses such as septic complications.<sup><xref ref-type="bibr" rid="bibr122-2156587213477864">122</xref></sup> Fermented milk supplemented with 2 probiotic strains, <italic>Bifidobacterium lactis</italic> Bi-07 and <italic>Lactobacillus acidophilus</italic> NCFM, and a prebiotic, isomaltooligosaccharide, administered to healthy adults and mice improved intestinal health as indicated by increases in fecal bifidobacteria and lactobacilli and decreases in enterobacilli.<sup><xref ref-type="bibr" rid="bibr123-2156587213477864">123</xref></sup> Humoral and cell-mediated immunity have also been improved by the same tested synbiotics in mice.<sup><xref ref-type="bibr" rid="bibr123-2156587213477864">123</xref></sup> The combination of <italic>Lactobacillus acidophilus</italic> and ginger extract improved ulcer index, mucus secretion, oxidative stress, and histopathological parameters, when compared with the individual agents, in a gastric ulcer setting in rats.<sup><xref ref-type="bibr" rid="bibr124-2156587213477864">124</xref></sup>
</p>
<p>Very few studies have described the effects of synbiotics on reducing the severity of mucositis. Smith et al tested the combination of <italic>Lactobacillus fermentum</italic> BR11 and the prebiotic, fructo-oligosaccharide, in 5-fluorouracil-injected rats.<sup><xref ref-type="bibr" rid="bibr36-2156587213477864">36</xref></sup> These investigators found that <italic>Lactobacillus fermentum</italic> BR11 partially reduced the inflammation caused by 5-fluorouracil in the small intestine in rats. However, the combination did not provide additional therapeutic benefit for mucositis. Further studies are required to test the effects of combinations of different probiotics and prebiotics on reducing the severity of mucositis.</p>
<p>The prebiotic potential of virtually all plant extracts identified to date remains essentially unexplored. New nutraceuticals, including probiotics, probiotic factors, prebiotics, and plant extracts, hold the potential to decrease gut damage through different mechanisms, thereby increasing the likelihood of achieving clinically measurable net benefit. For example, certain probiotics could combat mucositis through effects on bacterial composition in the bowel whereas certain plant extracts would likely be more potent at counteracting oxidative stress created by chemotherapy. Therefore, indicated combinations of probiotics (or probiotic factors) and plant extracts could potentially reduce the severity of mucositis to a greater extent than each of the agents used independently, thereby potentially achieving measurable clinical improvement.</p>
<p>As the majority of prebiotics are derived from plants, future studies could focus on determining the prebiotic properties of a wider range of plant extracts. Future challenges will include mechanisms to identify specific combinations of probiotics and prebiotics that exert synergistic benefits in mucositis treatment. Determining dosing regimens, frequency of administration, the specific bioactive factors involved, and their associated pharmacodynamics will represent further challenges before these promising new nutraceutical formulations can be recommended for mucositis treatment.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>The authors would like to thank Anna and Scoresby Shepherd for assistance in reviewing this article.</p>
</ack>
<fn-group>
<fn fn-type="other" id="fn1-2156587213477864">
<label>Author Contributions</label>
<p>All the authors have contributed to the preparation of this review.</p>
</fn>
<fn fn-type="conflict" id="fn2-2156587213477864">
<label>Declaration of Conflicting Interests</label>
<p>The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure" id="fn3-2156587213477864">
<label>Funding</label>
<p>The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Professor Gordon Howarth is supported by a Cancer Council South Australian Health and Medical Research Institute Senior Research Fellowship.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-2156587213477864">
<label>1</label>
<citation citation-type="web">
<collab collab-type="author">Queensland Government</collab>. <article-title>Cancer</article-title>. <ext-link ext-link-type="uri" xlink:href="http://access.health.qld.gov.au/hid/Cancer/WhatisCancer/cancer_fs.asp">http://access.health.qld.gov.au/hid/Cancer/WhatisCancer/cancer_fs.asp</ext-link>. <comment>Accessed November 26, 2012</comment>.</citation>
</ref>
<ref id="bibr2-2156587213477864">
<label>2</label>
<citation citation-type="web">
<person-group person-group-type="author">
<name>
<surname>Cancer Research</surname>
<given-names>UK</given-names>
</name>
</person-group>. <article-title>What cancer is</article-title>. <ext-link ext-link-type="uri" xlink:href="http://cancerhelp.cancerresearchuk.org/about-cancer/what-is-cancer/cells/what-cancer-is">http://cancerhelp.cancerresearchuk.org/about-cancer/what-is-cancer/cells/what-cancer-is</ext-link>. <comment>Accessed November 26, 2012</comment>.</citation>
</ref>
<ref id="bibr3-2156587213477864">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lima</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Dinis-Ribeiro</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Longatto-Filho</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Santos</surname>
<given-names>L.</given-names>
</name>
</person-group> <article-title>Predictive biomarkers of bacillus calmette-guerin immunotherapy response in bladder cancer: where are we now?</article-title> <source>Adv Urol</source>. <year>2012</year>;<volume>2012</volume>:<fpage>232609</fpage>.</citation>
</ref>
<ref id="bibr4-2156587213477864">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Narayan</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>A.</given-names>
</name>
</person-group> <article-title>Constitutive over expression of IL-1β, IL-6, NF-κB, and Stat3 is a potential cause of lung tumorgenesis in urethane (ethyl carbamate) induced Balb/c mice</article-title>. <source>J Carcinog</source>. <year>2012</year>;<volume>11</volume>:<fpage>9</fpage>.</citation>
</ref>
<ref id="bibr5-2156587213477864">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Villarreal-Garza</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Shaw-Dulin</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Lara-Medina</surname>
<given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>Impact of diabetes and hyperglycemia on survival in advanced breast cancer patients</article-title>. <source>Exp Diabetes Res</source>. <year>2012</year>;<volume>2012</volume>:<fpage>732027</fpage>.</citation>
</ref>
<ref id="bibr6-2156587213477864">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kahlert</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Gaitzsch</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Steinert</surname>
<given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>Expression analysis of aldehyde dehydrogenase 1A1 (ALDH1A1) in colon and rectal cancer in association with prognosis and response to chemotherapy</article-title>. <source>Ann Surg Oncol</source>. <year>2012</year>;<volume>19</volume>:<fpage>4193</fpage>–<lpage>4201</lpage>.</citation>
</ref>
<ref id="bibr7-2156587213477864">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Teras</surname>
<given-names>LR</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>AV</given-names>
</name>
<name>
<surname>Hildebrand</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Gapstur</surname>
<given-names>SM.</given-names>
</name>
</person-group> <article-title>Postmenopausal unopposed estrogen and estrogen plus progestin use and risk of non-Hodgkin lymphoma in the American Cancer Society Cancer Prevention Study-II Cohort [published online September 14, 2012]</article-title>. <source>Leuk Lymphoma</source>. <comment>doi:10.3109/10428194.2012.722216</comment>.</citation>
</ref>
<ref id="bibr8-2156587213477864">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Colas</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Pedrola</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Devis</surname>
<given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>The EMT signaling pathways in endometrial carcinoma</article-title>. <source>Clin Transl Oncol</source>. <year>2012</year>;<volume>14</volume>:<fpage>715</fpage>–<lpage>720</lpage>.</citation>
</ref>
<ref id="bibr9-2156587213477864">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pazienza</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Tavano</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Benegiamo</surname>
<given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>Correlations among PPARγ, DNMT1, and DNMT3B expression levels and pancreatic cancer</article-title>. <source>PPAR Res</source>. <year>2012</year>;<volume>2012</volume>:<fpage>461784</fpage>.</citation>
</ref>
<ref id="bibr10-2156587213477864">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lou</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W</given-names>
</name>
</person-group>. <article-title>Expression profiling based graph-clustering approach to determine renal carcinoma related pathway in response to kidney cancer</article-title>. <source>Eur Rev Med Pharmacol Sci</source>. <year>2012</year>;<volume>16</volume>:<fpage>775</fpage>–<lpage>780</lpage>.</citation>
</ref>
<ref id="bibr11-2156587213477864">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andreotti</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Koutros</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Berndt</surname>
<given-names>SI</given-names>
</name>
<etal/>
</person-group>. <article-title>The interaction between pesticide use and genetic variants involved in lipid metabolism on prostate cancer risk</article-title>. <source>J Cancer Epidemiol</source>. <year>2012</year>;<volume>2012</volume>:<fpage>358076</fpage>.</citation>
</ref>
<ref id="bibr12-2156587213477864">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Witt</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Milde</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Deubzer</surname>
<given-names>HE</given-names>
</name>
<etal/>
</person-group>. <article-title>Phase I/II intra-patient dose escalation study of vorinostat in children with relapsed solid tumor, lymphoma or leukemia</article-title>. <source>Klin Padiatr</source>. <year>2012</year>;<volume>224</volume>:<fpage>398</fpage>–<lpage>403</lpage>.</citation>
</ref>
<ref id="bibr13-2156587213477864">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bellelli</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Castellone</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Garcia-Rostan</surname>
<given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>FOXM1 is a molecular determinant of the mitogenic and invasive phenotype of anaplastic thyroid carcinoma</article-title>. <source>Endocr Relat Cancer</source>. <year>2012</year>;<volume>19</volume>:<fpage>695</fpage>–<lpage>710</lpage>.</citation>
</ref>
<ref id="bibr14-2156587213477864">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lorusso</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Mancini</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Di Rocco</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Fontanelli</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Raspagliesi</surname>
<given-names>F</given-names>
</name>
</person-group>. <article-title>The role of secondary surgery in recurrent ovarian cancer</article-title>. <source>Int J Surg Oncol</source>. <year>2012</year>;<volume>2012</volume>:<fpage>613980</fpage>.</citation>
</ref>
<ref id="bibr15-2156587213477864">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wietek</surname>
<given-names>BM</given-names>
</name>
<name>
<surname>Kratt</surname>
<given-names>T</given-names>
</name>
</person-group>. <article-title>Current MRI staging of rectal cancer</article-title>. <source>Rofo</source>. <year>2012</year>;<volume>184</volume>:<fpage>992</fpage>–<lpage>1001</lpage>.</citation>
</ref>
<ref id="bibr16-2156587213477864">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Waldmann</surname>
<given-names>TA</given-names>
</name>
</person-group>. <article-title>Immunotherapy: past, present and future</article-title>. <source>Nat Med</source>. <year>2003</year>;<volume>9</volume>:<fpage>269</fpage>–<lpage>277</lpage>.</citation>
</ref>
<ref id="bibr17-2156587213477864">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gibson</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Monje</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Effect of cancer therapy on neural stem cells: implications for cognitive function</article-title>. <source>Curr Opin Oncol</source>. <year>2012</year>;<volume>24</volume>:<fpage>672</fpage>–<lpage>678</lpage>.</citation>
</ref>
<ref id="bibr18-2156587213477864">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Decker-Baumann</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Buhl</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Frohmüller</surname>
<given-names>S</given-names>
</name>
<name>
<surname>von Herbay</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Dueck</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Schlag</surname>
<given-names>PM</given-names>
</name>
</person-group>. <article-title>Reduction of chemotherapy-induced side-effects by parenteral glutamine supplementation in patients with metastatic colorectal cancer</article-title>. <source>Eur J Cancer</source>. <year>1999</year>;<volume>35</volume>:<fpage>202</fpage>–<lpage>207</lpage>.</citation>
</ref>
<ref id="bibr19-2156587213477864">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sonis</surname>
<given-names>ST</given-names>
</name>
</person-group>. <article-title>Oral mucositis in cancer therapy</article-title>. <source>J Support Oncol</source>. <year>2004</year>;<volume>2</volume>:<fpage>3</fpage>–<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr20-2156587213477864">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sonis</surname>
<given-names>ST</given-names>
</name>
<name>
<surname>Elting</surname>
<given-names>LS</given-names>
</name>
<name>
<surname>Keefe</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients</article-title>. <source>Cancer</source>. <year>2004</year>;<volume>100</volume>:<fpage>1995</fpage>–<lpage>2025</lpage>.</citation>
</ref>
<ref id="bibr21-2156587213477864">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sonis</surname>
<given-names>ST</given-names>
</name>
</person-group>. <article-title>A biological approach to mucositis</article-title>. <source>J Support Oncol</source>. <year>2004</year>;<volume>2</volume>:<fpage>21</fpage>–<lpage>32</lpage>.</citation>
</ref>
<ref id="bibr22-2156587213477864">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Keefe</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Schubert</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Elting</surname>
<given-names>LS</given-names>
</name>
<etal/>
</person-group>. <article-title>Updated clinical practice guidelines for the prevention and treatment of mucositis</article-title>. <source>Cancer</source>. <year>2007</year>;<volume>109</volume>:<fpage>820</fpage>–<lpage>831</lpage>.</citation>
</ref>
<ref id="bibr23-2156587213477864">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duncan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Grant</surname>
<given-names>G</given-names>
</name>
</person-group>. <article-title>Oral and intestinal mucositis—causes and possible treatments</article-title>. <source>Aliment Pharmacol Ther</source>. <year>2003</year>;<volume>18</volume>:<fpage>853</fpage>–<lpage>874</lpage>.</citation>
</ref>
<ref id="bibr24-2156587213477864">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stringer</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Gibson</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Logan</surname>
<given-names>RM</given-names>
</name>
<etal/>
</person-group>. <article-title>Gastrointestinal microflora and mucins may play a critical role in the development of 5-fluorouracil-induced gastrointestinal mucositis</article-title>. <source>Exp Biol Med (Maywood)</source>. <year>2009</year>;<volume>234</volume>:<fpage>430</fpage>–<lpage>441</lpage>.</citation>
</ref>
<ref id="bibr25-2156587213477864">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Keefe</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Brealey</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Goland</surname>
<given-names>GJ</given-names>
</name>
<name>
<surname>Cummins</surname>
<given-names>AG</given-names>
</name>
</person-group>. <article-title>Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans</article-title>. <source>Gut</source>. <year>2000</year>;<volume>47</volume>:<fpage>632</fpage>–<lpage>637</lpage>.</citation>
</ref>
<ref id="bibr26-2156587213477864">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sonis</surname>
<given-names>S</given-names>
</name>
</person-group>. <article-title>Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity</article-title>. <source>Oral Oncol</source>. <year>1998</year>;<volume>34</volume>:<fpage>39</fpage>–<lpage>43</lpage>.</citation>
</ref>
<ref id="bibr27-2156587213477864">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lalla</surname>
<given-names>RV</given-names>
</name>
<name>
<surname>Peterson</surname>
<given-names>DE</given-names>
</name>
</person-group>. <article-title>Treatment of mucositis, including new medications</article-title>. <source>Cancer J</source>. <year>2006</year>;<volume>12</volume>:<fpage>348</fpage>–<lpage>354</lpage>.</citation>
</ref>
<ref id="bibr28-2156587213477864">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Howarth</surname>
<given-names>GS</given-names>
</name>
<name>
<surname>Cool</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Bourne</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Ballard</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>Read</surname>
<given-names>LC</given-names>
</name>
</person-group>. <article-title>Insulin-like growth factor-I (IGF-I) stimulates regrowth of the damaged intestine in rats, when administered following, but not concurrent with, methotrexate</article-title>. <source>Growth Factors</source>. <year>1998</year>;<volume>15</volume>:<fpage>279</fpage>–<lpage>292</lpage>.</citation>
</ref>
<ref id="bibr29-2156587213477864">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sonis</surname>
<given-names>ST</given-names>
</name>
</person-group>. <article-title>Pathobiology of mucositis</article-title>. <source>Semin Oncol Nurs</source>. <year>2004</year>;<volume>20</volume>:<fpage>11</fpage>–<lpage>15</lpage>.</citation>
</ref>
<ref id="bibr30-2156587213477864">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodríguez-Caballero</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Torres-Lagares</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Robles-García</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pachón-Ibáñez</surname>
<given-names>J</given-names>
</name>
<name>
<surname>González-Padilla</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Gutiérrez-Pérez</surname>
<given-names>JL</given-names>
</name>
</person-group>. <article-title>Cancer treatment-induced oral mucositis: a critical review</article-title>. <source>Int J Oral Maxillofac Surg</source>. <year>2012</year>;<volume>41</volume>:<fpage>225</fpage>–<lpage>238</lpage>.</citation>
</ref>
<ref id="bibr31-2156587213477864">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Howarth</surname>
<given-names>GS</given-names>
</name>
<name>
<surname>Francis</surname>
<given-names>GL</given-names>
</name>
<name>
<surname>Cool</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Byard</surname>
<given-names>RW</given-names>
</name>
<name>
<surname>Read</surname>
<given-names>LC</given-names>
</name>
</person-group>. <article-title>Milk growth factors enriched from cheese whey ameliorate intestinal damage by methotrexate when administered orally to rats</article-title>. <source>J Nutr</source>. <year>1996</year>;<volume>126</volume>:<fpage>2519</fpage>–<lpage>2530</lpage>.</citation>
</ref>
<ref id="bibr32-2156587213477864">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Howarth</surname>
<given-names>GS</given-names>
</name>
</person-group>. <article-title>Insulin-like growth factor-I and the gastrointestinal system: therapeutic indications and safety implications</article-title>. <source>J Nutr</source>. <year>2003</year>;<volume>133</volume>:<fpage>2109</fpage>–<lpage>2112</lpage>.</citation>
</ref>
<ref id="bibr33-2156587213477864">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bowen</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Stringer</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Gibson</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Yeoh</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Hannam</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Keefe</surname>
<given-names>DM</given-names>
</name>
</person-group>. <article-title>VSL#3 probiotic treatment reduces chemotherapy-induced diarrhea and weight loss</article-title>. <source>Cancer Biol Ther</source>. <year>2007</year>;<volume>6</volume>:<fpage>1449</fpage>–<lpage>1454</lpage>.</citation>
</ref>
<ref id="bibr34-2156587213477864">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tooley</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Howarth</surname>
<given-names>GS</given-names>
</name>
<name>
<surname>Lymn</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Lawrence</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Butler</surname>
<given-names>RN</given-names>
</name>
</person-group>. <article-title>Oral ingestion of streptococcus thermophilus diminishes severity of small intestinal mucositis in methotrexate treated rats</article-title>. <source>Cancer Biol Ther</source>. <year>2006</year>;<volume>5</volume>:<fpage>593</fpage>–<lpage>600</lpage>.</citation>
</ref>
<ref id="bibr35-2156587213477864">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prisciandaro</surname>
<given-names>LD</given-names>
</name>
<name>
<surname>Geier</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Chua</surname>
<given-names>AE</given-names>
</name>
<etal/>
</person-group>. <article-title>Probiotic factors partially prevent changes to caspases 3 and 7 activation and transepithelial electrical resistance in a model of 5-fluorouracil-induced epithelial cell damage</article-title>. <source>Support Care Cancer</source>. <year>2012</year>;<volume>20</volume>:<fpage>3205</fpage>–<lpage>3210</lpage>.</citation>
</ref>
<ref id="bibr36-2156587213477864">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Geier</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Yazbeck</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Torres</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Butler</surname>
<given-names>RN</given-names>
</name>
<name>
<surname>Howarth</surname>
<given-names>GS.</given-names>
</name>
</person-group> <article-title>
<italic>Lactobacillus fermentum</italic> BR11 and fructo-oligosaccharide partially reduce jejunal inflammation in a model of intestinal mucositis in rats</article-title>. <source>Nutr Cancer</source>. <year>2008</year>;<volume>60</volume>:<fpage>757</fpage>–<lpage>767</lpage>.</citation>
</ref>
<ref id="bibr37-2156587213477864">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prisciandaro</surname>
<given-names>LD</given-names>
</name>
<name>
<surname>Geier</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Butler</surname>
<given-names>RN</given-names>
</name>
<name>
<surname>Cummins</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Howarth</surname>
<given-names>GS</given-names>
</name>
</person-group>. <article-title>Probiotic factors partially improve parameters of 5-fluorouracil-induced intestinal mucositis in rats</article-title>. <source>Cancer Biol Ther</source>. <year>2011</year>;<volume>11</volume>:<fpage>671</fpage>–<lpage>677</lpage>.</citation>
</ref>
<ref id="bibr38-2156587213477864">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wright</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>Yazbeck</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Lymn</surname>
<given-names>KA</given-names>
</name>
<etal/>
</person-group>. <article-title>The herbal extract, Iberogast, improves jejunal integrity in rats with 5-fluorouracil (5-FU)-induced mucositis</article-title>. <source>Cancer Biol Ther</source>. <year>2009</year>;<volume>8</volume>:<fpage>923</fpage>–<lpage>929</lpage>.</citation>
</ref>
<ref id="bibr39-2156587213477864">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheah</surname>
<given-names>KY</given-names>
</name>
<name>
<surname>Howarth</surname>
<given-names>GS</given-names>
</name>
<name>
<surname>Yazbeck</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Grape seed extract protects IEC-6 cells from chemotherapy-induced cytotoxicity and improves parameters of small intestinal mucositis in rats with experimentally-induced mucositis</article-title>. <source>Cancer Biol Ther</source>. <year>2009</year>;<volume>8</volume>:<fpage>382</fpage>–<lpage>390</lpage>.</citation>
</ref>
<ref id="bibr40-2156587213477864">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Torres</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Tooley</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Butler</surname>
<given-names>RN</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Geier</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Howarth</surname>
<given-names>GS</given-names>
</name>
</person-group>. <article-title>Lyprinol only partially improves indicators of small intestinal integrity in a rat model of 5-fluorouracil-induced mucositis</article-title>. <source>Cancer Biol Ther</source>. <year>2008</year>;<volume>7</volume>:<fpage>295</fpage>–<lpage>302</lpage>.</citation>
</ref>
<ref id="bibr41-2156587213477864">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abimosleh</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Tran</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Howarth</surname>
<given-names>GS</given-names>
</name>
</person-group>. <article-title>Emu oil: a novel therapeutic for disorders of the gastrointestinal tract?</article-title> <source>J Gastroenterol Hepatol</source>. <year>2012</year>;<volume>27</volume>:<fpage>857</fpage>–<lpage>861</lpage>.</citation>
</ref>
<ref id="bibr42-2156587213477864">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reid</surname>
<given-names>G</given-names>
</name>
</person-group>. <article-title>The importance of guidelines in the development and application of probiotics</article-title>. <source>Curr Pharm Des</source>. <year>2005</year>;<volume>11</volume>:<fpage>11</fpage>–<lpage>16</lpage>.</citation>
</ref>
<ref id="bibr43-2156587213477864">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Borchers</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Selmi</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Meyers</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>Keen</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Gershwin</surname>
<given-names>ME</given-names>
</name>
</person-group>. <article-title>Probiotics and immunity</article-title>. <source>J Gastroenterol</source>. <year>2009</year>;<volume>44</volume>:<fpage>26</fpage>–<lpage>46</lpage>.</citation>
</ref>
<ref id="bibr44-2156587213477864">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>GT</given-names>
</name>
<name>
<surname>Ferket</surname>
<given-names>PR</given-names>
</name>
<etal/>
</person-group>. <article-title>Effects of probiotic, <italic>Clostridium butyricum</italic>, on growth performance, immune function, and cecal microflora in broiler chickens</article-title>. <source>Poult Sci</source>. <year>2012</year>;<volume>91</volume>:<fpage>2121</fpage>–<lpage>2129</lpage>.</citation>
</ref>
<ref id="bibr45-2156587213477864">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moro-Garcia</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Alonso-Arias</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Baltadjieva</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Oral supplementation with <italic>Lactobacillus delbrueckii</italic> subsp. bulgaricus 8481 enhances systemic immunity in elderly subjects [published online May 30, 2012]</article-title>. <source>Age (Dordr)</source>. <comment>doi:10.1007/s11357-012-9434-6</comment>.</citation>
</ref>
<ref id="bibr46-2156587213477864">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tanriover</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Aksoy</surname>
<given-names>DY</given-names>
</name>
<name>
<surname>Unal</surname>
<given-names>S</given-names>
</name>
</person-group>. <article-title>Use of probiotics in various diseases: evidence and promises</article-title>. <source>Pol Arch Med Wewn</source>. <year>2012</year>;<volume>122</volume>(<issue>suppl 1</issue>):<fpage>72</fpage>–<lpage>77</lpage>.</citation>
</ref>
<ref id="bibr47-2156587213477864">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schultz</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Clinical use of <italic>E. coli</italic> Nissle 1917 in inflammatory bowel disease</article-title>. <source>Inflamm Bowel Dis</source>. <year>2008</year>;<volume>14</volume>:<fpage>1012</fpage>–<lpage>1018</lpage>.</citation>
</ref>
<ref id="bibr48-2156587213477864">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Howarth</surname>
<given-names>GS</given-names>
</name>
</person-group>. <article-title>Probiotic-derived factors: probiotaceuticals?</article-title> <source>J Nutr</source>. <year>2010</year>;<volume>140</volume>:<fpage>229</fpage>–<lpage>230</lpage>.</citation>
</ref>
<ref id="bibr49-2156587213477864">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prisciandaro</surname>
<given-names>LD</given-names>
</name>
<name>
<surname>Geier</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Butler</surname>
<given-names>RN</given-names>
</name>
<name>
<surname>Cummins</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Howarth</surname>
<given-names>GS</given-names>
</name>
</person-group>. <article-title>Evidence supporting the use of probiotics for the prevention and treatment of chemotherapy-induced intestinal mucositis</article-title>. <source>Crit Rev Food Sci Nutr</source>. <year>2011</year>;<volume>51</volume>:<fpage>239</fpage>–<lpage>247</lpage>.</citation>
</ref>
<ref id="bibr50-2156587213477864">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lukic</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Strahinic</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Jovcic</surname>
<given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>Different roles of lactococcal aggregation factor and mucin binding protein in adhesion to gastrointestinal mucosa</article-title>. <source>Appl Environ Microbiol</source>. <year>2012</year>;<volume>78</volume>:<fpage>7993</fpage>–<lpage>8000</lpage>.</citation>
</ref>
<ref id="bibr51-2156587213477864">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gonzalez-Rodriguez</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Sanchez</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Ruiz</surname>
<given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Role of extracellular transaldolase from <italic>Bifidobacterium bifidum</italic> in mucin adhesion and aggregation</article-title>. <source>Appl Environ Microbiol</source>. <year>2012</year>;<volume>78</volume>:<fpage>3992</fpage>–<lpage>3998</lpage>.</citation>
</ref>
<ref id="bibr52-2156587213477864">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bujnakova</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kmet</surname>
<given-names>V</given-names>
</name>
</person-group>. <article-title>Functional properties of <italic>Lactobacillus</italic> strains isolated from dairy products</article-title>. <source>Folia Microbiol (Praha)</source>. <year>2012</year>;<volume>57</volume>:<fpage>263</fpage>–<lpage>267</lpage>.</citation>
</ref>
<ref id="bibr53-2156587213477864">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aloisio</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Santini</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Biavati</surname>
<given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>Characterization of <italic>Bifidobacterium</italic> spp. strains for the treatment of enteric disorders in newborns</article-title>. <source>Appl Microbiol Biotechnol</source>. <year>2012</year>;<volume>96</volume>:<fpage>1561</fpage>–<lpage>1576</lpage>.</citation>
</ref>
<ref id="bibr54-2156587213477864">
<label>54</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>XW</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>JH</given-names>
</name>
<etal/>
</person-group>. <article-title>Effect of perioperative intestinal probiotics on intestinal flora and immune function in patients with colorectal cancer</article-title>. <source>Nan Fang Yi Ke Da Xue Xue Bao</source>. <year>2012</year>;<volume>32</volume>:<fpage>1190</fpage>–<lpage>1193</lpage>.</citation>
</ref>
<ref id="bibr55-2156587213477864">
<label>55</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Corridoni</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Pastorelli</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Mattioli</surname>
<given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>Probiotic bacteria regulate intestinal epithelial permeability in experimental ileitis by a TNF-dependent mechanism</article-title>. <source>PLoS One</source>. <year>2012</year>;<volume>7</volume>:<fpage>e42067</fpage>.</citation>
</ref>
<ref id="bibr56-2156587213477864">
<label>56</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harhaj</surname>
<given-names>NS</given-names>
</name>
<name>
<surname>Antonetti</surname>
<given-names>DA</given-names>
</name>
</person-group>. <article-title>Regulation of tight junctions and loss of barrier function in pathophysiology</article-title>. <source>Int J Biochem Cell Biol</source>. <year>2004</year>;<volume>36</volume>:<fpage>1206</fpage>–<lpage>1237</lpage>.</citation>
</ref>
<ref id="bibr57-2156587213477864">
<label>57</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>YK</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>HL</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Effects of <italic>Lactobacillus plantarum</italic> on gut barrier function in experimental obstructive jaundice</article-title>. <source>World J Gastroenterol</source>. <year>2012</year>;<volume>18</volume>:<fpage>3977</fpage>–<lpage>3991</lpage>.</citation>
</ref>
<ref id="bibr58-2156587213477864">
<label>58</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>O’Callaghan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Buttó</surname>
<given-names>LF</given-names>
</name>
<name>
<surname>MacSharry</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Nally</surname>
<given-names>K</given-names>
</name>
<name>
<surname>O’Toole</surname>
<given-names>PW</given-names>
</name>
</person-group>. <article-title>Influence of adhesion and bacteriocin production by <italic>Lactobacillus salivarius</italic> on the intestinal epithelial cell transcriptional response</article-title>. <source>Appl Environ Microbiol</source>. <year>2012</year>;<volume>78</volume>:<fpage>5196</fpage>–<lpage>5203</lpage>.</citation>
</ref>
<ref id="bibr59-2156587213477864">
<label>59</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hudcovic</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kolinska</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Klepetar</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Protective effect of <italic>Clostridium tyrobutyricum</italic> in acute dextran sodium sulphate-induced colitis: differential regulation of tumour necrosis factor-alpha and interleukin-18 in BALB/c and severe combined immunodeficiency mice</article-title>. <source>Clin Exp Immunol</source>. <year>2012</year>;<volume>167</volume>:<fpage>356</fpage>–<lpage>365</lpage>.</citation>
</ref>
<ref id="bibr60-2156587213477864">
<label>60</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duary</surname>
<given-names>RK</given-names>
</name>
<name>
<surname>Bhausaheb</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Batish</surname>
<given-names>VK</given-names>
</name>
<name>
<surname>Grover</surname>
<given-names>S</given-names>
</name>
</person-group>. <article-title>Anti-inflammatory and immunomodulatory efficacy of indigenous probiotic Lactobacillus plantarum Lp91 in colitis mouse model</article-title>. <source>Mol Biol Rep</source>. <year>2012</year>;<volume>39</volume>:<fpage>4765</fpage>–<lpage>4775</lpage>.</citation>
</ref>
<ref id="bibr61-2156587213477864">
<label>61</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>PW</given-names>
</name>
<name>
<surname>Nasr</surname>
<given-names>TR</given-names>
</name>
<name>
<surname>Berardinelli</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Neish</surname>
<given-names>AS</given-names>
</name>
</person-group>. <article-title>The probiotic <italic>Lactobacillus</italic> GG may augment intestinal host defense by regulating apoptosis and promoting cytoprotective responses in the developing murine gut</article-title>. <source>Pediatr Res</source>. <year>2008</year>;<volume>64</volume>:<fpage>511</fpage>–<lpage>516</lpage>.</citation>
</ref>
<ref id="bibr62-2156587213477864">
<label>62</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guma</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Firestein</surname>
<given-names>GS.</given-names>
</name>
</person-group> <article-title>c-Jun N-terminal kinase in inflammation and rheumatic diseases</article-title>. <source>Open Rheumatol J</source>. <year>2012</year>;<volume>6</volume>:<fpage>220</fpage>–<lpage>231</lpage>.</citation>
</ref>
<ref id="bibr63-2156587213477864">
<label>63</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>HF</given-names>
</name>
<name>
<surname>Tseng</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>MH</given-names>
</name>
<etal/>
</person-group>. <article-title>Anti-inflammatory effects of probiotic <italic>Lactobacillus paracasi</italic> on ventricles of BALB/C mice treated with ovalbumin</article-title>. <source>Chin J Physiol</source>. <year>2012</year>;<volume>55</volume>:<fpage>37</fpage>–<lpage>46</lpage>.</citation>
</ref>
<ref id="bibr64-2156587213477864">
<label>64</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hadrup</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Strindhall</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kollgaard</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly</article-title>. <source>J Immunol</source>. <year>2006</year>;<volume>176</volume>:<fpage>2645</fpage>–<lpage>2653</lpage>.</citation>
</ref>
<ref id="bibr65-2156587213477864">
<label>65</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yan</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Cover</surname>
<given-names>TL</given-names>
</name>
<name>
<surname>Whitehead</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Washington</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Polk</surname>
<given-names>DB</given-names>
</name>
</person-group>. <article-title>Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth</article-title>. <source>Gastroenterology</source>. <year>2007</year>;<volume>132</volume>:<fpage>562</fpage>–<lpage>575</lpage>.</citation>
</ref>
<ref id="bibr66-2156587213477864">
<label>66</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Forsyth</surname>
<given-names>CB</given-names>
</name>
<name>
<surname>Farhadi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Jakate</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Shaikh</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Keshavarzian</surname>
<given-names>A.</given-names>
</name>
</person-group> <article-title>
<italic>Lactobacillus</italic> GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis</article-title>. <source>Alcohol</source>. <year>2009</year>;<volume>43</volume>:<fpage>163</fpage>–<lpage>172</lpage>.</citation>
</ref>
<ref id="bibr67-2156587213477864">
<label>67</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Sidhu</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>McClain</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>W.</given-names>
</name>
</person-group> <article-title>
<italic>Lactobacillus</italic> rhamnosus GG culture supernatant ameliorates acute alcohol-induced intestinal permeability and liver injury</article-title>. <source>Am J Physiol Gastrointest Liver Physiol</source>. <year>2012</year>;<volume>303</volume>:<fpage>G32</fpage>–<lpage>G41</lpage>.</citation>
</ref>
<ref id="bibr68-2156587213477864">
<label>68</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Talarico</surname>
<given-names>TL</given-names>
</name>
<name>
<surname>Dobrogosz</surname>
<given-names>WJ</given-names>
</name>
</person-group>. <article-title>Chemical characterization of an antimicrobial substance produced by <italic>Lactobacillus reuteri</italic>
</article-title>. <source>Antimicrob Agents Chemother</source>. <year>1989</year>;<volume>33</volume>:<fpage>674</fpage>–<lpage>679</lpage>.</citation>
</ref>
<ref id="bibr69-2156587213477864">
<label>69</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Campana</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Federici</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ciandrini</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Baffone</surname>
<given-names>W</given-names>
</name>
</person-group>. <article-title>Antagonistic activity of <italic>Lactobacillus acidophilus</italic> ATCC 4356 on the growth and adhesion/invasion characteristics of human <italic>Campylobacter jejuni</italic>
</article-title>. <source>Curr Microbiol</source>. <year>2012</year>;<volume>64</volume>:<fpage>371</fpage>–<lpage>378</lpage>.</citation>
</ref>
<ref id="bibr70-2156587213477864">
<label>70</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fayol-Messaoudi</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Berger</surname>
<given-names>CN</given-names>
</name>
<name>
<surname>Coconnier-Polter</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Liévin-Le Moal</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Servin</surname>
<given-names>AL.</given-names>
</name>
</person-group> <article-title>pH-, lactic acid-, and non-lactic acid-dependent activities of probiotic <italic>Lactobacilli</italic> against <italic>Salmonella enterica</italic> Serovar Typhimurium</article-title>. <source>Appl Environ Microbiol</source>. <year>2005</year>;<volume>71</volume>:<fpage>6008</fpage>–<lpage>6013</lpage>.</citation>
</ref>
<ref id="bibr71-2156587213477864">
<label>71</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pridmore</surname>
<given-names>RD</given-names>
</name>
<name>
<surname>Pittet</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Praplan</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Cavadini</surname>
<given-names>C</given-names>
</name>
</person-group>. <article-title>Hydrogen peroxide production by <italic>Lactobacillus johnsonii</italic> NCC 533 and its role in anti-Salmonella activity</article-title>. <source>FEMS Microbiol Lett</source>. <year>2008</year>;<volume>283</volume>:<fpage>210</fpage>–<lpage>215</lpage>.</citation>
</ref>
<ref id="bibr72-2156587213477864">
<label>72</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kirpich</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>
<italic>Lactobacillus rhamnosus</italic> GG treatment potentiates intestinal hypoxia-inducible factor, promotes intestinal integrity and ameliorates alcohol-induced liver injury</article-title>. <source>Am J Pathol</source>. <year>2011</year>;<volume>179</volume>:<fpage>2866</fpage>–<lpage>2875</lpage>.</citation>
</ref>
<ref id="bibr73-2156587213477864">
<label>73</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Song</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>ZQ</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>PY</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>PC</given-names>
</name>
</person-group>. <article-title>Probiotics promote endocytic allergen degradation in gut epithelial cells</article-title>. <source>Biochem Biophys Res Commun</source>. <year>2012</year>;<volume>426</volume>:<fpage>135</fpage>–<lpage>140</lpage>.</citation>
</ref>
<ref id="bibr74-2156587213477864">
<label>74</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lebeer</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Claes</surname>
<given-names>IJ</given-names>
</name>
<name>
<surname>Balog</surname>
<given-names>CI</given-names>
</name>
<etal/>
</person-group>. <article-title>The major secreted protein Msp1/p75 is O-glycosylated in <italic>Lactobacillus rhamnosus</italic> GG</article-title>. <source>Microb Cell Fact</source>. <year>2012</year>;<volume>11</volume>:<fpage>15</fpage>.</citation>
</ref>
<ref id="bibr75-2156587213477864">
<label>75</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ménard</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Candalh</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bambou</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Terpend</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Cerf-Bensussan</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Heyman</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Lactic acid bacteria secrete metabolites retaining anti-inflammatory properties after intestinal transport</article-title>. <source>Gut</source>. <year>2004</year>;<volume>53</volume>:<fpage>821</fpage>–<lpage>828</lpage>.</citation>
</ref>
<ref id="bibr76-2156587213477864">
<label>76</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jones</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Versalovic</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>Probiotic <italic>Lactobacillus reuteri</italic> biofilms produce antimicrobial and anti-inflammatory factors</article-title>. <source>BMC Microbiol</source>. <year>2009</year>;<volume>9</volume>:<fpage>35</fpage>.</citation>
</ref>
<ref id="bibr77-2156587213477864">
<label>77</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nemeth</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Fajdiga</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Malago</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Koninkx</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Tooten</surname>
<given-names>P</given-names>
</name>
<name>
<surname>van Dijk</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>Inhibition of <italic>Salmonella</italic>-induced IL-8 synthesis and expression of Hsp70 in enterocyte-like Caco-2 cells after exposure to non-starter lactobacilli</article-title>. <source>Int J Food Microbiol</source>. <year>2006</year>;<volume>112</volume>:<fpage>266</fpage>–<lpage>274</lpage>.</citation>
</ref>
<ref id="bibr78-2156587213477864">
<label>78</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bermudez-Brito</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Munoz-Quezada</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gomez-Llorente</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Human intestinal dendritic cells decrease cytokine release against <italic>Salmonella</italic> infection in the presence of <italic>Lactobacillus paracasei</italic> upon TLR activation</article-title>. <source>PLoS One</source>. <year>2012</year>;<volume>7</volume>:<fpage>e43197</fpage>.</citation>
</ref>
<ref id="bibr79-2156587213477864">
<label>79</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lopez</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Gonzalez-Rodriguez</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Sanchez</surname>
<given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>Interaction of <italic>Bifidobacterium bifidum</italic> LMG13195 with HT29 cells influences regulatory-T-cell-associated chemokine receptor expression</article-title>. <source>Appl Environ Microbiol</source>. <year>2012</year>;<volume>78</volume>:<fpage>2850</fpage>–<lpage>2857</lpage>.</citation>
</ref>
<ref id="bibr80-2156587213477864">
<label>80</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roberfroid</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gibson</surname>
<given-names>GR</given-names>
</name>
<name>
<surname>Hoyles</surname>
<given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Prebiotic effects: metabolic and health benefits</article-title>. <source>Br J Nutr</source>. <year>2010</year>;<volume>104</volume>(<issue>suppl 2</issue>):<fpage>S1</fpage>–<lpage>63</lpage>.</citation>
</ref>
<ref id="bibr81-2156587213477864">
<label>81</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Looijer-van Langen</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Dieleman</surname>
<given-names>LA</given-names>
</name>
</person-group>. <article-title>Prebiotics in chronic intestinal inflammation</article-title>. <source>Inflamm Bowel Dis</source>. <year>2009</year>;<volume>15</volume>:<fpage>454</fpage>–<lpage>462</lpage>.</citation>
</ref>
<ref id="bibr82-2156587213477864">
<label>82</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abrams</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Griffin</surname>
<given-names>IJ</given-names>
</name>
<name>
<surname>Hawthorne</surname>
<given-names>KM</given-names>
</name>
<etal/>
</person-group>. <article-title>A combination of prebiotic short- and long-chain inulin-type fructans enhances calcium absorption and bone mineralization in young adolescents</article-title>. <source>Am J Clin Nutr</source>. <year>2005</year>;<volume>82</volume>:<fpage>471</fpage>–<lpage>476</lpage>.</citation>
</ref>
<ref id="bibr83-2156587213477864">
<label>83</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bovee-Oudenhoven</surname>
<given-names>IM</given-names>
</name>
<name>
<surname>ten Bruggencate</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Lettink-Wissink</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>van der Meer</surname>
<given-names>R</given-names>
</name>
</person-group>. <article-title>Dietary fructo-oligosaccharides and lactulose inhibit intestinal colonisation but stimulate translocation of salmonella in rats</article-title>. <source>Gut</source>. <year>2003</year>;<volume>52</volume>:<fpage>1572</fpage>–<lpage>1578</lpage>.</citation>
</ref>
<ref id="bibr84-2156587213477864">
<label>84</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alliet</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Scholtens</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Raes</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Effect of prebiotic galacto-oligosaccharide, long-chain fructo-oligosaccharide infant formula on serum cholesterol and triacylglycerol levels</article-title>. <source>Nutrition</source>. <year>2007</year>;<volume>23</volume>:<fpage>719</fpage>–<lpage>723</lpage>.</citation>
</ref>
<ref id="bibr85-2156587213477864">
<label>85</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cherbut</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Michel</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lecannu</surname>
<given-names>G</given-names>
</name>
</person-group>. <article-title>The prebiotic characteristics of fructooligosaccharides are necessary for reduction of TNBS-induced colitis in rats</article-title>. <source>J Nutr</source>. <year>2003</year>;<volume>133</volume>:<fpage>21</fpage>–<lpage>27</lpage>.</citation>
</ref>
<ref id="bibr86-2156587213477864">
<label>86</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maki</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Gibson</surname>
<given-names>GR</given-names>
</name>
<name>
<surname>Dickmann</surname>
<given-names>RS</given-names>
</name>
<etal/>
</person-group>. <article-title>Digestive and physiologic effects of a wheat bran extract, arabino-xylan-oligosac-charide, in breakfast cereal</article-title>. <source>Nutrition</source>. <year>2012</year>;<volume>28</volume>:<fpage>1115</fpage>–<lpage>1121</lpage>.</citation>
</ref>
<ref id="bibr87-2156587213477864">
<label>87</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Piao</surname>
<given-names>XS</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>SW</given-names>
</name>
<etal/>
</person-group>. <article-title>Effects of chito-oligosaccharide supplementation on the growth performance, nutrient digestibility, intestinal morphology, and fecal shedding of <italic>Escherichia coli</italic> and <italic>Lactobacillus</italic> in weaning pigs</article-title>. <source>J Anim Sci</source>. <year>2008</year>;<volume>86</volume>:<fpage>2609</fpage>–<lpage>2618</lpage>.</citation>
</ref>
<ref id="bibr88-2156587213477864">
<label>88</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nishimukai</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Taguchi</surname>
<given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Effects of epilactose on calcium absorption and serum lipid metabolism in rats</article-title>. <source>J Agric Food Chem</source>. <year>2008</year>;<volume>56</volume>:<fpage>10340</fpage>–<lpage>10345</lpage>.</citation>
</ref>
<ref id="bibr89-2156587213477864">
<label>89</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kanauchi</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Oshima</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Andoh</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Shioya</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mitsuyama</surname>
<given-names>K</given-names>
</name>
</person-group>. <article-title>Germinated barley foodstuff ameliorates inflammation in mice with colitis through modulation of mucosal immune system</article-title>. <source>Scand J Gastroenterol</source>. <year>2008</year>;<volume>43</volume>:<fpage>1346</fpage>–<lpage>1352</lpage>.</citation>
</ref>
<ref id="bibr90-2156587213477864">
<label>90</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Iji</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Kocher</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Thomson</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Mikkelsen</surname>
<given-names>LL</given-names>
</name>
<name>
<surname>Choct</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Effects of mannanoligosaccharide in broiler chicken diets on growth performance, energy utilisation, nutrient digestibility and intestinal microflora</article-title>. <source>Br Poult Sci</source>. <year>2008</year>;<volume>49</volume>:<fpage>186</fpage>–<lpage>194</lpage>.</citation>
</ref>
<ref id="bibr91-2156587213477864">
<label> 91</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sinclair</surname>
<given-names>HR</given-names>
</name>
<name>
<surname>Smejkal</surname>
<given-names>CW</given-names>
</name>
<name>
<surname>Glister</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Sialyloligosaccharides inhibit cholera toxin binding to the GM1 receptor</article-title>. <source>Carbohydr Res</source>. <year>2008</year>;<volume>343</volume>:<fpage>2589</fpage>–<lpage>2594</lpage>.</citation>
</ref>
<ref id="bibr92-2156587213477864">
<label> 92</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Q</given-names>
</name>
</person-group>. <article-title>Effect of prebiotic xylooligosaccharides on growth performances and digestive enzyme activities of allogynogenetic crucian carp (Carassius auratus gibelio)</article-title>. <source>Fish Physiol Biochem</source>. <year>2009</year>;<volume>35</volume>:<fpage>351</fpage>–<lpage>357</lpage>.</citation>
</ref>
<ref id="bibr93-2156587213477864">
<label> 93</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ibuki</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kovacs-Nolan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Fukui</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kanatani</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Mine</surname>
<given-names>Y</given-names>
</name>
</person-group>. <article-title>Analysis of gut immune-modulating activity of beta-1,4-mannobiose using microarray and real-time reverse transcription polymerase chain reaction</article-title>. <source>Poult Sci</source>. <year>2010</year>;<volume>89</volume>:<fpage>1894</fpage>–<lpage>1904</lpage>.</citation>
</ref>
<ref id="bibr94-2156587213477864">
<label> 94</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Geier</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Howarth</surname>
<given-names>GS.</given-names>
</name>
</person-group> <article-title>Prebiotics: a potential treatment strategy for the chemotherapy-damaged gut?</article-title> <source>Crit Rev Food Sci Nutr</source>. <year>In press</year>.</citation>
</ref>
<ref id="bibr95-2156587213477864">
<label> 95</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bogusławska-Tryk</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Piotrowska</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Burlikowska</surname>
<given-names>K</given-names>
</name>
</person-group>. <article-title>Dietary fructans and their potential beneficial influence on health and performance parameters in broiler chickens</article-title>. <source>J Cent Eur Agric</source>. <year>2012</year>;<volume>13</volume>:<fpage>272</fpage>–<lpage>291</lpage>.</citation>
</ref>
<ref id="bibr96-2156587213477864">
<label> 96</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leforestier</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Blais</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Blachier</surname>
<given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>Effects of galacto-oligosaccharide ingestion on the mucosa-associated mucins and sucrase activity in the small intestine of mice</article-title>. <source>Eur J Nutr</source>. <year>2009</year>;<volume>48</volume>:<fpage>457</fpage>–<lpage>464</lpage>.</citation>
</ref>
<ref id="bibr97-2156587213477864">
<label> 97</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abdelouhab</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Rafa</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Toumi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Bouaziz</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Medjeber</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Touil-Boukoffa</surname>
<given-names>C</given-names>
</name>
</person-group>. <article-title>Mucosal intestinal alteration in experimental colitis correlates with nitric oxide production by peritoneal macrophages: effect of probiotics and prebiotics</article-title>. <source>Immunopharmacol Immunotoxicol</source>. <year>2012</year>;<volume>34</volume>:<fpage>590</fpage>–<lpage>597</lpage>.</citation>
</ref>
<ref id="bibr98-2156587213477864">
<label> 98</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Howarth</surname>
<given-names>GS</given-names>
</name>
</person-group>. <article-title>Commentary on prebiotic utility in colitis: will inflammasomics hold the key?</article-title> <source>J Nutr</source>. <year>2012</year>;<volume>142</volume>:<fpage>1189</fpage>–<lpage>1190</lpage>.</citation>
</ref>
<ref id="bibr99-2156587213477864">
<label> 99</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gonzales</surname>
<given-names>GF</given-names>
</name>
<name>
<surname>Valerio</surname>
<given-names>LG</given-names>
<suffix>Jr</suffix>
</name>
</person-group>. <article-title>Medicinal plants from Peru: a review of plants as potential agents against cancer</article-title>. <source>Anticancer Agents Med Chem</source>. <year>2006</year>;<volume>6</volume>:<fpage>429</fpage>–<lpage>444</lpage>.</citation>
</ref>
<ref id="bibr100-2156587213477864">
<label>100</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bravo</surname>
<given-names>L</given-names>
</name>
</person-group>. <article-title>Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance</article-title>. <source>Nutr Rev</source>. <year>1998</year>;<volume>56</volume>:<fpage>317</fpage>–<lpage>333</lpage>.</citation>
</ref>
<ref id="bibr101-2156587213477864">
<label>101</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fine</surname>
<given-names>AM</given-names>
</name>
</person-group>. <article-title>Oligomeric proanthocyanidin complexes: history, structure, and phytopharmaceutical applications</article-title>. <source>Altern Med Rev</source>. <year>2000</year>;<volume>5</volume>:<fpage>144</fpage>–<lpage>151</lpage>.</citation>
</ref>
<ref id="bibr102-2156587213477864">
<label>102</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Schwitters</surname>
<given-names>B</given-names>
</name>
</person-group>. <source>OPC in Practice: The Hidden Story of Proanthocyanidins</source>. <edition>2nd ed</edition>. <publisher-loc>Rome, Italy</publisher-loc>: <publisher-name>Alfa Omega Editrice</publisher-name>; <year>1993</year>.</citation>
</ref>
<ref id="bibr103-2156587213477864">
<label>103</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bagchi</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Sen</surname>
<given-names>CK</given-names>
</name>
<name>
<surname>Ray</surname>
<given-names>SD</given-names>
</name>
<etal/>
</person-group>. <article-title>Molecular mechanisms of cardioprotection by a novel grape seed proanthocyanidin extract</article-title>. <source>Mutat Res</source>. <year>2003</year>;<volume>523-524</volume>:<fpage>87</fpage>–<lpage>97</lpage>.</citation>
</ref>
<ref id="bibr104-2156587213477864">
<label>104</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Erlejman</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Fraga</surname>
<given-names>CG</given-names>
</name>
<name>
<surname>Oteiza</surname>
<given-names>PI</given-names>
</name>
</person-group>. <article-title>Procyanidins protect Caco-2 cells from bile acid- and oxidant-induced damage</article-title>. <source>Free Radic Biol Med</source>. <year>2006</year>;<volume>41</volume>:<fpage>1247</fpage>–<lpage>1256</lpage>.</citation>
</ref>
<ref id="bibr105-2156587213477864">
<label>105</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geronikaki</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Gavalas</surname>
<given-names>AM</given-names>
</name>
</person-group>. <article-title>Antioxidants and inflammatory disease: synthetic and natural antioxidants with anti-inflammatory activity</article-title>. <source>Comb Chem High Throughput Screen</source>. <year>2006</year>;<volume>9</volume>:<fpage>425</fpage>–<lpage>442</lpage>.</citation>
</ref>
<ref id="bibr106-2156587213477864">
<label>106</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kalin</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Righi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Del Rosso</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Activin, a grape seed-derived proanthocyanidin extract, reduces plasma levels of oxidative stress and adhesion molecules (ICAM-1, VCAM-1 and E-selectin) in systemic sclerosis</article-title>. <source>Free Radic Res</source>. <year>2002</year>;<volume>36</volume>:<fpage>819</fpage>–<lpage>825</lpage>.</citation>
</ref>
<ref id="bibr107-2156587213477864">
<label>107</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Banan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Fields</surname>
<given-names>JZ</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Shaikh</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Farhadi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Keshavarzian</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>Zeta isoform of protein kinase C prevents oxidant-induced nuclear factor-kappaB activation and I-kappaBalpha degradation: a fundamental mechanism for epidermal growth factor protection of the microtubule cytoskeleton and intestinal barrier integrity</article-title>. <source>J Pharmacol Exp Ther</source>. <year>2003</year>;<volume>307</volume>:<fpage>53</fpage>–<lpage>66</lpage>.</citation>
</ref>
<ref id="bibr108-2156587213477864">
<label>108</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Keshavarzian</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Banan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Farhadi</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Increases in free radicals and cytoskeletal protein oxidation and nitration in the colon of patients with inflammatory bowel disease</article-title>. <source>Gut</source>. <year>2003</year>;<volume>52</volume>:<fpage>720</fpage>–<lpage>728</lpage>.</citation>
</ref>
<ref id="bibr109-2156587213477864">
<label>109</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gulgun</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Erdem</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Oztas</surname>
<given-names>E</given-names>
</name>
<etal/>
</person-group>. <article-title>Proanthocyanidin prevents methotrexate-induced intestinal damage and oxidative stress</article-title>. <source>Exp Toxicol Pathol</source>. <year>2010</year>;<volume>62</volume>:<fpage>109</fpage>–<lpage>115</lpage>.</citation>
</ref>
<ref id="bibr110-2156587213477864">
<label>110</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Erlejman</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Verstraeten</surname>
<given-names>SV</given-names>
</name>
<name>
<surname>Fraga</surname>
<given-names>CG</given-names>
</name>
<name>
<surname>Oteiza</surname>
<given-names>PI</given-names>
</name>
</person-group>. <article-title>The interaction of flavonoids with membranes: potential determinant of flavonoid antioxidant effects</article-title>. <source>Free Radic Res</source>. <year>2004</year>;<volume>38</volume>:<fpage>1311</fpage>–<lpage>1320</lpage>.</citation>
</ref>
<ref id="bibr111-2156587213477864">
<label>111</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verstraeten</surname>
<given-names>SV</given-names>
</name>
<name>
<surname>Hammerstone</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Keen</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Fraga</surname>
<given-names>CG</given-names>
</name>
<name>
<surname>Oteiza</surname>
<given-names>PI</given-names>
</name>
</person-group>. <article-title>Antioxidant and membrane effects of procyanidin dimers and trimers isolated from peanut and cocoa</article-title>. <source>J Agric Food Chem</source>. <year>2005</year>;<volume>53</volume>:<fpage>5041</fpage>–<lpage>5048</lpage>.</citation>
</ref>
<ref id="bibr112-2156587213477864">
<label>112</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Facino</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Carini</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Aldini</surname>
<given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>Diet enriched with procyanidins enhances antioxidant activity and reduces myocardial post-ischaemic damage in rats</article-title>. <source>Life Sci</source>. <year>1999</year>;<volume>64</volume>:<fpage>627</fpage>–<lpage>642</lpage>.</citation>
</ref>
<ref id="bibr113-2156587213477864">
<label>113</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Busserolles</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gueux</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Balasinska</surname>
<given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>In vivo antioxidant activity of procyanidin-rich extracts from grape seed and pine (<italic>Pinus maritima</italic>) bark in rats</article-title>. <source>Int J Vitam Nutr Res</source>. <year>2006</year>;<volume>76</volume>:<fpage>22</fpage>–<lpage>27</lpage>.</citation>
</ref>
<ref id="bibr114-2156587213477864">
<label>114</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Joshi</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Kuszynski</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Benner</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Bagchi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bagchi</surname>
<given-names>D</given-names>
</name>
</person-group>. <article-title>Amelioration of the cytotoxic effects of chemotherapeutic agents by grape seed proanthocyanidin extract</article-title>. <source>Antioxid Redox Signal</source>. <year>1999</year>;<volume>1</volume>:<fpage>563</fpage>–<lpage>570</lpage>.</citation>
</ref>
<ref id="bibr115-2156587213477864">
<label>115</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bak</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Jun</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jeong</surname>
<given-names>WS</given-names>
</name>
</person-group>. <article-title>Procyanidins from wild grape (<italic>Vitis amurensis</italic>) seeds regulate ARE-mediated enzyme expression via Nrf2 coupled with p38 and PI3K/Akt pathway in HepG2 Cells</article-title>. <source>Int J Mol Sci</source>. <year>2012</year>;<volume>13</volume>:<fpage>801</fpage>–<lpage>818</lpage>.</citation>
</ref>
<ref id="bibr116-2156587213477864">
<label>116</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iwasaki</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Matsui</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Arakawa</surname>
<given-names>Y</given-names>
</name>
</person-group>. <article-title>The protective and hormonal effects of proanthocyanidin against gastric mucosal injury in Wistar rats</article-title>. <source>J Gastroenterol</source>. <year>2004</year>;<volume>39</volume>:<fpage>831</fpage>–<lpage>837</lpage>.</citation>
</ref>
<ref id="bibr117-2156587213477864">
<label>117</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garbacki</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Tits</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Angenot</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Damas</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>Inhibitory effects of proanthocyanidins from <italic>Ribes nigrum</italic> leaves on carrageenin acute inflammatory reactions induced in rats</article-title>. <source>BMC Pharmacol</source>. <year>2004</year>;<volume>4</volume>:<fpage>25</fpage>.</citation>
</ref>
<ref id="bibr118-2156587213477864">
<label>118</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wegener</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Wagner</surname>
<given-names>H</given-names>
</name>
</person-group>. <article-title>The active components and the pharmacological multi-target principle of STW 5 (Iberogast)</article-title>. <source>Phytomedicine</source>. <year>2006</year>;<volume>13</volume>(<issue>suppl 5</issue>):<fpage>20</fpage>–<lpage>35</lpage>.</citation>
</ref>
<ref id="bibr119-2156587213477864">
<label>119</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shiota</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hada</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Baba</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Protective effects of glycoglycerolipids extracted from spinach on 5-fluorouracil induced intestinal mucosal injury</article-title>. <source>J Med Invest</source>. <year>2010</year>;<volume>57</volume>:<fpage>314</fpage>–<lpage>320</lpage>.</citation>
</ref>
<ref id="bibr120-2156587213477864">
<label>120</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takuma</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Guangchen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yokota</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Effect of <italic>Eriobotrya japonica</italic> seed extract on 5-fluorouracil-induced mucositis in hamsters</article-title>. <source>Biol Pharm Bull</source>. <year>2008</year>;<volume>31</volume>:<fpage>250</fpage>–<lpage>254</lpage>.</citation>
</ref>
<ref id="bibr121-2156587213477864">
<label>121</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>You</surname>
<given-names>WC</given-names>
</name>
<name>
<surname>Hsieh</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>JT</given-names>
</name>
</person-group>. <article-title>Effect of extracts from indigowood root (<italic>Isatis indigotica</italic> Fort.) on immune responses in radiation-induced mucositis</article-title>. <source>J Altern Complement Med</source>. <year>2009</year>;<volume>15</volume>:<fpage>771</fpage>–<lpage>778</lpage>.</citation>
</ref>
<ref id="bibr122-2156587213477864">
<label>122</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shimizu</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ogura</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Asahara</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Probiotic/synbiotic therapy for treating critically ill patients from a gut microbiota perspective [published online August 19, 2012]</article-title>. <source>Dig Dis Sci</source>. <comment>doi:10.1007/s10620-10012-12334-x</comment>.</citation>
</ref>
<ref id="bibr123-2156587213477864">
<label>123</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Fermented milk supplemented with probiotics and prebiotics can effectively alter the intestinal microbiota and immunity of host animals</article-title>. <source>J Dairy Sci</source>. <year>2012</year>;<volume>95</volume>:<fpage>4813</fpage>–<lpage>4822</lpage>.</citation>
</ref>
<ref id="bibr124-2156587213477864">
<label>124</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>PK</given-names>
</name>
<name>
<surname>Kaur</surname>
<given-names>IP</given-names>
</name>
</person-group>. <article-title>Synbiotic (probiotic and ginger extract) loaded floating beads: a novel therapeutic option in an experimental paradigm of gastric ulcer</article-title>. <source>J Pharm Pharmacol</source>. <year>2012</year>;<volume>64</volume>:<fpage>207</fpage>–<lpage>217</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>